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ABSTRACT 
 
Tissue Engineering Approaches for the  
Treatment of Knee Joint Damage. (May 2011) 
Rebecca Erin McMahon, B.S., Rensselaer Polytechnic Institute 
Co-Chairs of Advisory Committee: Dr. Mariah Hahn  
 Dr. Michael Pishko 
 
 
 There are more than 150,000 anterior cruciate ligament reconstructions each year 
with the goal of recovering the balance between knee stability and mobility. As many as 
25% of these procedures will end in joint instability that can cause further damage. The 
risk of developing degenerative joint disease (DJD) increases in patients with previous 
knee injury, resulting in a higher instance of total knee arthroplasty  (TKA). 
 There are more than 400,000 TKA procedures each year, but the waiting lists for 
this surgery shows that many more patients are hoping to undergo this procedure. TKA 
provides improved knee function and pain relief for patients suffering from DJD. 
Although this procedure is considered successful, as younger patients undergo this 
treatment, the long-term performance must be improved. Major mechanisms of failure 
include component loosening from stress-shielding, poor integration of the implant with 
native tissue, and ion release from the implant. TiNb alloys are more biocompatible than 
currently used alloys, such as NiTi, and have mechanical properties closer to bone, so 
they would reduce the instance of stress shielding. TiNb can be made porous for better 
integration with the native bone and has superior corrosion resistance than NiTi.
 Engineered ligaments have generally failed to achieve mechanical properties 
sufficiently similar to their native counterparts, but also lack the osteochondral interface 
critical to the transfer of load between ligament and bone. The osteochondral interface 
could be incorporated through a gradient of inorganic content toward the bony insertion 
ends of the ligament graft, as we showed that in increase of inorganic content resulted in 
 iv 
the transdifferentiation of osteoblasts toward chondrocyte-like cells (bone to cartilage-
like). 
A composite scaffold composed of an electrospun mesh with either a hydrogel 
component or extracellular matrix (ECM) produced by the cells may be a suitable tissue 
engineered ligament graft. The non-linear stress-strain behavior seen in native ligament 
is exhibited by both of these systems, and the ECM produced by these systems is 
consistent with ligament tissue. The ECM-electrospun mesh composite exhibited higher 
elastic modulus than the fibrin-electrospun mesh composite, but required extensive pre 
culture while the fibrin-electrospun mesh composite could be fabricated in situ.  
 v 
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CHAPTER I 
INTRODUCTION 
 
The number of patients on organ transplant lists far exceeds the number of organs 
available for transplant. These numbers do not account for patients with tissue damage 
such as burn victims, patients with critical sized bone defects, vascular disease, or any 
number of other conditions, which would benefit from tissue replacement. At present, 
physicians generally treat organ or tissue loss by transplanting organs from one 
individual to another, by performing reconstructive surgeries, or by using mechanical 
devices such as kidney dialyzers. Tissue engineering emerged from this shortfall in 
available tissue or organs and from issues surrounding long term use of external 
mechanical devices. The knee is the most injured joint and requires 400,000 total knee 
replacements per year.
1
 Many of these come from patients with previous knee damage, 
like ligament ruptures, but many more come from sufferers of degenerative joint disease. 
Over 150,000 anterior cruciate ligament (ACL) reconstruction surgeries are performed 
each year due to damage or rupture of ligaments causing instability in the knee joint,
2
 
which can cause further knee damage if left untreated.
3-5
 Tissue engineering could 
potentially provide improved ligament grafts to reduce the progressive degeneration of 
joints following injury. Tissue engineering principles could also be applied to improve 
the long-term success of total knee replacements. An understanding of the knee anatomy 
may provide the information necessary to improve the lives of patients with debilitating 
pain and low quality of life.  
 
1.1 Native Knee Anatomy 
 
An understanding of the normal anatomy of the knee, one of the most injured  
 
_______________ 
This dissertation follows the style of Journal of Biomedical Materials Research Part A. 
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joints (shown in Figure 1), provides the insight for the design of tissue engineered 
approaches for the treatment of knee joint damage. The bones of the knee, the femur and 
the tibia, meet to form a hinge joint. Both of these bones are covered by a layer of 
cartilage that cushions the bones. The meniscus is a pad of cartilage that acts as a shock 
absorber to further cushion the joint. Damage to cartilage in the knee due to 
osteoarthritis or injury is the primary cause of knee pain.
6
 The collateral ligaments run 
along the sides of the knee to limit sideways motion and the cruciate ligaments cross in 
the center of the knee.  The anterior cruciate ligament (ACL) limits rotation and forward 
motion of the tibia, while the posterior cruciate ligament limits backward motion of the 
tibia. Knee injuries can span a range from injuries of the ligament alone to total joint 
damage. Each of these requires different treatment approaches.  
 
 
 
Figure 1: Anatomy of a healthy knee 
7
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1.2 Current Treatments 
 
The treatment for knee joint damage depends on the extent of injury or damage. 
The ACL is the most commonly injured ligament in the knee, yet this tissue has limited 
ability to heal. The incidence of knee ligament injuries have been estimated to be as 
many as 2 people in 1000 per year in the general population
8
 and much higher in those 
involved in sports.
9
 Ligament rupture can upset the balance between knee stability and 
mobility. Left untreated, this injury can result in damage to other parts of the joint 
leading to pain and morbidity, so surgery is the typical treatment. Ligament 
reconstruction surgery limits the potential for long-term knee instability, further damage 
to other parts of the knee, or progressive degeneration,
3-5
 by restoring tibiofemoral 
stability, which can minimize the risk of further damage to the knee.
10,11
 The ligament 
reconstruction procedure includes removing and replacing the existing tendon with 
either the central third of the patellar ligament or the hamstring tendons with fairly 
similar outcomes.
12-16
 Bone tunnels are drilled into the tibial and femoral heads and the 
tendon or ligament is attached inside the tunnel using a metal or degradable PLLA 
screw.
17,18
 There are more that 150,000 ligament reconstruction surgeries per year,
2
 and 
while the majority of these procedures yield good short term results, up to 25% of 
patients experience complication including instability that can damage other knee 
structures.
19-23
 An increased risk of developing degenerative joint disease exists after 
severe injury such as rupture of the ACL,
20,21
 but even after a successful reconstructive 
surgery, loss of graft tension of failure of graft fixation can cause increased knee 
instability.
24,25
 This instability along with articular cartilage and meniscal damage 
associated with ACL injury or rupture may be the cause of osteoarthritis later in life in 
many of these patients.  
Several authors describe an increased danger of degenerative joint disease after a 
severe injury such as a traumatic rupture of the ACL,
20,21
 which, in turn, increases the 
need for these patients to undergo total knee arthroplasty (TKA). With extensive knee 
damage due to disease or progressive degeneration following injury, TKA is often 
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performed as it provides improved knee function and pain relief. Currently there are over 
380,000 TKA procedures in the US each year-- some to those with complications of 
ligament reconstructions, but many more from sufferers of degenerative disease-- but the 
waiting lists for this surgery show that many more patients are hoping to undergo this 
procedure. Without alternative treatments for degenerative knee disease, it is projected 
that by 2030, 3.4 million patients will undergo total knee replacements each year. This 
procedure involves removing the distal end of the femur and the proximal end of the 
tibia, then replacing the knee joint with a metal and plastic implant. Although 94-98% of 
TKA are still functional after 10-14 years,
26,27
 there are a number of problems associated 
with this procedure, and with younger patients undergoing this surgery, the long-term 
performance of this implant is of increased importance. 
Despite the advances in TKA technology, the major mechanisms of failure 
include polyethylene wear and component loosening.
23
 There are many mechanisms of 
loosening, including stress shielding
28
 which is caused by a mismatch between the 
mechanical properties of the implant and the native bone, ion leaching from the 
implant,
29
 and poor ingrowth of bone into the implant. My project looks to use tissue 
engineering (TE) to improve the prospects for patients with less severe injuries, like 
ligament damage, but also for patients with extensive damage that requires TKA. 
It is important to note the work in cartilage tissue engineering, whose progress 
may one day reduce the need for TKA procedures. Transplantation of chondrocytes or 
differentiated cells have been studied with a success rate of less than 40% due to the 
problem of retaining the cells in the defect for the length of time required to produce 
matrix.
30,31
 Another study implanted autologous chondrocytes below a periosteal flap 
with better results over 5-10 years, but requires the harvest of periosteal tissue.
32
 Cells 
encapsulated within a scaffold have also been investigated as a treatment for joint pain 
due to cartilage damage. The biomaterial can generally be injected to fill any shape or 
size defect then polymerized.
33,34
  Although, cartilage tissue engineering doesn‟t treat the 
problem of degenerative joint disease, if used to treat injuries fairly soon after the 
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damage, perhaps this will delay the onset of or reduce the instance of degenerative joint 
disease, which may reduce the instance of TKA. 
The understanding of materials and biology makes tissue engineering a discipline 
that has the potential to improve both ligament reconstruction surgeries and knee 
replacements.  
 
1.3 Tissue Engineering 
 
The modern era of TE began only about 25 years ago. In 1993, Langer and 
Vacanti defined TE as an interdisciplinary field that applies the principle of engineering 
and the life sciences toward the development of biological substitutes that restore, 
maintain, or improve tissue function.
35
 The initial focus of this discipline involved in 
vitro creation of replacement tissues for simple tissues, like skin. The interest in 
designing more complex tissues than partial-thickness skin substitutes made it clear that 
the direct assembly of different cell types would be inadequate to recreate the structure 
and function of complex tissues. The basic principle of present TE is the combination of 
appropriate cells with biomaterials under conditions that promote and lead to tissue 
formation. In general, there are three strategies used to treat diseased or injured tissues. 
Cells from the patient or a donor can be implanted into the defect, either directly, or after 
being combined with a scaffold material. Alternatively, patient or donor cells can be 
grown on a scaffold to create a 3D tissue in vitro and then implanted after the construct 
has reached maturity. Finally, a scaffold material alone can be implanted directly and 
this material can stimulate the surrounding cells to promote local tissue repair.
36
  
The assembly of cells into tissues is a complicated process where cells take cues 
from their microenvironmental niche. Each tissue provides a unique microenvironment 
with varying conditions such as: oxygen concentration, pH, available nutrients, 
mechanical forces, cytokine gradients, and ionic and electric potential. The complexity 
of the mature tissue development process can currently be aided with bioreactors, but the 
effect is limited. Implanting constructs into the body may aid in this development, but 
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the appropriate choice of cells and scaffold could determine the success or failure of this 
approach. Ideally, the scaffold would degrade at a similar rate as extracellular matrix 
(ECM) deposition so that eventually only the generated tissue would remain.  
Tissue engineering and regenerative medicine present a possible solution to 
many common knee problems and potential improvements to current treatments. Less 
stiff and more biologically inert metal alloys such as Ti alloys have been applied with 
success and excellent bone ingrowth into porous materials. Tissue engineered ligament 
grafts may be applied without the common problems associated with currently used 
grafts such as autografts, which can cause pain and donor site morbidity. 
 
1.4 Cell Source 
 
Cell source became a limitation for the design and commercial application of 
tissue engineered constructs as the first tissue engineered constructs either relied on 
migration of host cells into scaffolds, with limited success, or used adult cells in the 
design of constructs.
37
 Mature autologous cells are a good option for tissue engineered 
constructs, but may not always be available, viable, or capable of the proliferation 
necessary for forming new tissue.  
With the discovery and better understanding of adult and embryonic stem cell 
biology, and more recently induced pluripotent stem cells, cell source became less of a 
problem in tissue engineering. Mesenchymal stem cells have the ability to differentiate 
into many mesenchymal cell types, like bone, cartilage, fat, dermis, muscle, bone 
marrow stroma, and ligament/tendon, making them a good candidate for ligament tissue 
engineering. Many researchers are interested in bone marrow derived mesenchymal stem 
cells as stem cells for many tissues.
38
  
The ability to heal following injury is reduced as humans age. This can be 
explained by the decline in the number of MSCs in the bone marrow.(Shown in Figure 
2) Knee injury often occurs in adults, with very low MSCs per bone marrow cells, so 
these cells may not be the best option for ligament tissue engineering applications. 
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Adipose tissue is fairly simple to extract and contains high levels of MSCs.
39
 These cells 
are thought to be associated with the blood vessels within these tissues.
40
 Adipose 
derived MSCs could potentially be a viable option for treatment of knee joint damage 
due to their mesenchymal differentiation potential and the abundance in adipose tissue. 
 
 
Figure 2 : Human MSC Decline with Age (Adapted from Caplan) 
41
 
 
 
1.5 Biomaterial Choice 
 
A tissue engineering scaffold is a material that supports the cells for their growth, 
proliferation, and differentiation in the absence of native ECM. For bone applications, 
like in total joint replacements, metals act as a scaffold and should be porous to promote 
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bone ingrowth, which can secure the implant to reduce loosening. For soft tissues, such 
as ligament, the mechanical properties of polymers more closely match native tissues.   
The ECM was originally thought to act only as a mechanical support for the 
cells, but through receptors on the surface of cells, the ECM takes part in promoting cell 
adhesion, migration, growth, differentiation, and apoptosis.
42
 Ideally, a tissue engineered 
scaffold should mimic both the form and function of native ECM. Like any other 
biomaterial for implantation, a tissue engineered scaffold should be biocompatible and 
not initiate tissue reactions or immune responses. For most applications, the scaffold 
should be biodegradable at a rate that allows cells to produce ECM to fill the void left 
from the degrading scaffold. With proper scaffold selection, there will be no fibrous 
encapsulation of the materials and the newly formed tissue with integrate with the 
surrounding tissue in a way that leaves no residual evidence of implantation.
43
  
Current biodegradable materials do not provide the necessary mechanical 
properties for joint replacement applications, so metals are used fairly successfully. 
Metal processing and coatings can produce porous scaffolds that promote bone ingrowth 
and cell differentiation. 
 
1.6 Experimental Plan 
 
My research focuses on applying tissue engineering principles to better the 
design of tissue engineering scaffolds for treating both ligament damage alone and total 
knee replacements. The overall approach to this work is outlined in Figure 3. 
In terms of total knee replacement, my work focuses on the metallic component 
and exploring alternatives to Nitinol (NiTi) alloys. The first objective of my work was 
therefore to determine the biocompatibility and corrosion resistance of a TiNb shape 
memory alloy (SMA) in physiological conditions. This material has properties that could 
be exploited for bone tissue engineering, vascular stents, and medical and dental wires. It 
could potentially replace NiTi, which has controversial biocompatibility, for most 
applications. 
 9 
 
Figure 3 : Scope of research 
 
In terms of ligament tissue engineering, electrospun mesh is an attractive scaffold 
for ligament tissue engineering because of the high tensile strength and aligned fibers 
which are suitable for the regeneration of oriented tissues, like ligament. Fabrication of 
electrospun meshes with dimension suitable for clinical application (e.g. 30 mm length 
by 7 mm in diameter for adult human ACL) is difficult as the generation of structures 
with thicknesses of 1 mm or greater is very time intensive. Therefore, a composite 
scaffold composed of the electrospun mesh embedded in a hydrogel matrix was 
developed as a ligament tissue engineering scaffold. These scaffolds were exposed to 
prolonged cyclic stretch to ensure that the scaffold was capable of withstanding 
elongation. The ECM production was analyzed to ensure deposition into the mesh and 
the presence of ligament ECM proteins.  To study the impact of the hydrogel component 
on the composite meshes, cylindrical meshes were fabricated without the hydrogel 
component by rolling cell-seeded meshes into a cylinder and tying the ends, then 
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allowing the ECM produced by the cells to secure the layers of mesh. Again, the ECM 
production and mechanical properties were analyzed and compared to those of the 
hydrogel-electrospun mesh composite.  
 Ligament graft failure frequently results from poor integration of the graft with 
associated bone, so the final objective dealt with the development of the osteochondral 
interface critical to the appropriate transfer of load between ligament and bone in native 
ligament. It was hypothesized that a gradient of PDMS in an inorganic-organic scaffold 
would induce an osteochondral-like transition in cell phenotype.   
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CHAPTER II 
BIOCOMPATIBILITY OF TINB SHAPE MEMORY ALLOY 
 FOR BONE TISSUE ENGINEERING 
 
2.1 Introduction 
 
Between 2005 and 2030, demand for hip replacement surgeries is projected to 
rise by 174% to almost 600,000 procedures per year, and the estimated rise for knee 
replacements is 673% to 3.48 million yearly procedures.
44
 These projections grossly 
underestimate the need for these surgeries, which is better reflected in hospital waiting 
lists. Joint replacement surgery is considered a highly successful procedure as measured 
by the reduction in pain and improvement in joint function, but as the number of 
procedures in younger patients rises, optimizing the success in terms of long-term 
survival of the prosthetic is required.
45
 One approach to improving the long-term 
survival of a joint implant includes introducing pores into the material to promote bone 
ingrowth, which would stabilize the implant and reduce the loosening. Another approach 
involves developing materials that have similar mechanical properties to bone to reduce 
stress shielding and the subsequent bone loss.
28
 Finally, ion release from metallic 
implants has been shown to cause loosening in joint replacements,
29
 so the selection of a 
more biocompatible and corrosion resistant material may reduce the prevalence of this 
problem. 
Metallic biomaterials such as titanium alloys, cobalt-chromium alloys, and 
stainless steels are used as implant materials for the replacement of structural 
components of the human body such as bones, joints, and tooth roots. Shape memory 
alloys (SMA) have the unique ability to recover their original shape upon heating and to 
sustain very large elastic strains, so they have been used for cardiovascular stents and 
medical and orthodontic wire.
46
 The combination of shape memory effect and 
superelasticity can be applied for orthopedic tissue engineering as the superelasticity 
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allows the design of devices with constant stress over a wide range of strains
47
, and this 
constant stress can accelerate healing. 
With recoverable strains of up to 8%, titanium-nickel (NiTi) SMAs, also known 
as Nitinol, are the most popular SMAs used for biomedical applications. In applications 
involving contact of SMAs with live tissues, biocompatibility is crucial to the success of 
the implant material.  The biocompatibility of NiTi alloys has been inferred from their 
high corrosion resistance
48-52
 due to a stable and passive TiO2 surface layer. This 
corrosion resistance depends on many factors though, and the malfunction of the 15 to 
30% of stents which fail within 6 months of implantation
53-55
 may be due, in part, to 
corrosion.  Along with the TiO2, there is also a small amount of elemental Ni in the 
surface layer of Nitinol.
56
 The nickel content in these materials has been controversial, as 
elemental nickel has been shown to be toxic
57-59
 and possibly carcinogenic.
60-62
 Also, 
4.5%
63
 to 8%
64
 of the general population are hypersensitive to nickel. Despite the nickel 
content, the results on the biocompatibility of Nitinol have been mixed. Multiple in vivo 
and in vitro studies have shown that Nitinol materials are at least as biocompatible as 
pure titanium.
56,57,65-70
 Yet, several other studies have challenged the corrosion resistance 
and safety of NiTi alloys in the body.
53-55,71-77
  
The concerns and unresolved issues associated with NiTi alloys, along with the 
growing need for implant materials, creates an urgent need for the design of nickel-free 
SMA with biocompatible constituents and better corrosion resistance. TiNb SMA 
systems have the potential to replace Nitinol in many applications.  The most obvious 
advantage of TiNb SMAs over NiTi is the biocompatibility of all constituents.
78
 The 
corrosion and wear resistance of TiNb has been shown to be superior to NiTi and Ti 
alone
78-81
 since both Ti and Nb can form protective oxide layers. In addition, if this layer 
were to be compromised it was demonstrated that Nb will be spontaneously passivated 
due to its low anodic current potential.
81
  Moreover, TiNb alloys are easy to process as 
compared to NiTi,
82
 with good machinability, 
83
 and their sensitivity to compositional 
change is considerably less than that of NiTi.
84
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TiNb alloy systems can recover as much as 4.5%  strain, 
85
 which although is less 
than the 8% recoverable strain that NiTi is capable of, should still be a suitable 
replacement for bone, which exhibits more than 1% recoverable strain. If deformation 
doesn‟t exceed the elastic limit, no damage to the material will result.86 For standard 
metals such as stainless steel, elastic strain is so small that plastic strain is generated 
during normal wear. When plastic deformation accumulates, cracking and eventually 
failure will occur, but this should not be a problem if using TiNb for joint replacement 
applications.  In its crystallographic orientation, TiNb alloys also possess very low 
Young‟s modulus, as low as 25 GPa,80 which is very close to the 20GPa of bone,87 and 
much lower than the 45-50 GPa modulus of NiTi single crystals.
80
 This is advantageous 
for load bearing implants, such as in joint replacements, as stress shielding can cause 
bone atrophy and eventual failure of the implant.
28
 
Porous materials are of importance for bone tissue engineering as they allow 
bone ingrowth and vascularization, which in turn provides a good integration/biological 
fixation of the biomaterial to the surrounding tissue.
88
 Porous materials have benefits 
including low density, high surface area, and high permeability, which allows for cell 
attachment and then ingrowth of tissue into the metallic scaffold. A great deal of 
literature has covered porous NiTi SMAs, but with the increased surface area, porous 
materials pose an increased risk of cytotoxicity because of the increased potential for ion 
leaching. Therefore, the choice of non-toxic materials is of increased importance when 
designing porous materials. The study of porous TiNb alloys is still in its infancy, but 
these materials have the potential to become a promising scaffold for bone tissue 
engineering. A porous TiNbZr scaffold was fabricated with high levels of interconnected 
pores,
89
 which is allows for cell growth and nutrient circulation.
90
  
Before pursuing TiNb SMAs as a potential biomaterial or further processing it to 
develop porous TiNb or vascular stent materials, the biocompatibility and corrosion 
resistance must be verified at physiological conditions.  
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2.2 Materials and Methods 
 
2.2.1 Metal and Alloy Preparation 
Ti74Nb26 (Special Metals) and Ni50.8Ti49.2 (Sophisticated Alloys; at.%) alloys with 
99.95% purity were produced using vacuum arc melting and were remelted four times to 
assure homogeneity.  Commercial pure grade 2 titanium (OnlineMetals), and 
commercial pure niobium (Alfa Aesar), both with 99.5% purity were utilized as controls.  
Square pieces with dimensions of 10 mm x 10 mm x 1 mm were prepared, and then both 
sides of all specimens were mechanically polished to a final step in 0.05 micron colloidal 
silica and cleaned with ethanol. 
 
2.2.2 Poly(ethylene glycol) Diacrylate Synthesis 
 Diacrylate-derivatized PEG (PEGDA) was prepared as previously described
91
 by 
combining 0.1 mmol/mL dry PEG (3.4 kDa; Sigma), 0.4 mmol/mL acryloyl chloride, 
and 0.2 mmol/mL triethylamine in anhydrous dichloromethane (DCM; Fisher Scientific) 
and stirring at 4 °C under argon overnight. The resulting solution was washed with 2 M 
K2CO3 and separated into aqueous and DCM phases to remove HCl. The DCM phase 
was subsequently dried with anhydrous MgSO4, and PEGDA was precipitated in diethyl 
ether, filtered, and dried under vacuum. 
 
2.2.3 Cell Culture 
Cryopreserved 3T3 cells (ATCC, Manassas, VA) at passages 4 were thawed and 
expanded at 37 
o
C and 5% CO2. During expansion, cells were cultured in Dulbecco‟s 
Modified Eagle‟s medium (DMEM; Hyclone, Logan, UT) containing 10% iron-
supplemented bovine calf serum (BCS; Hyclone), 100mU/mL penicillin, and 100mg/L 
streptomycin (Hyclone).  
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2.2.4 Short-term 2-D Culture Experiment 
To understand the short-term cytotoxic effect of these metals, an experiment was 
designed to maintain cells in contact with alloy leachants yet separate from the alloy 
surface.  In order to increase consistency of cell number between wells, mitomycin-c, an 
alkylating agent, was used to arrest the cell proliferation.  This treatment ensured that 
confluence was not reached by the end of the study to increase the likelihood of full 
exposure of the cells to the ions produced from the alloy. The 3T3 cells, passage 8-9, 
were exposed to 8 μg/ml mitomycin C (Sigma) for 3 hours at 37 oC. The cells were then 
allowed to recover from this treatment overnight before being treated with 1 μM calcein 
AM (Invitrogen), which was used to monitor cell phenotype and viability during culture.  
The alloys and metal controls were sterilized by soaking for 3 hours in 70% ethanol, 
then the ethanol was removed and the samples were allowed to dry. Following the 
ethanol treatment, the metals were rinsed with PBS and then placed into the wells. The 
metals and cells were cultured with DMEM supplemented with 10% FBS, 100 mU/mL 
penicillin, and 100 mg/L streptomycin and maintained at 37 
o
C/5% CO2. Culture media 
was collected for ion leaching analysis after 24, 48, and 72 hours of exposure. 
Cytotoxicity was assessed by LDH at the final time point. 
 
2.2.5 Short-term2-D Experiment Analysis 
Following 72 hours of culture, the cell culture inserts were treated with 1 mg/ml 
proteinase k in 1x TE buffer for 18 h at 37 
o
C to collect DNA. The DNA content was 
determined using the PicoGreen assay(Invitrogen).
92
 DNA measures were translated to 
cell number using a conversion factor of 6.6 pg DNA per cell
93
.  The cytotoxicity results 
were normalized by the cell number 
 
2.2.6 Hydrogel Preparation  
The behavior of cells is often dependent on culture conditions, as phenomena 
observed in two-dimensional culture are not necessarily observed in three dimensional 
culture. Therefore, to more closely mimic the environment in the body, a three-
 16 
dimensional study was designed with cells encapsulated in a PEGDA scaffold. The 
hydrogel precursor solution was prepared by dissolving PEGDA macromers in HEPES 
buffered saline (HBS; 10 mM HEPES, 150 mM NaCl, pH 7.4). Ten microliters of a 300 
mg/mL solution of photoinitiator 2, 2-dimethoxy-2-phenyl-acetophenone dissolved in N-
vinylpyrrolidone was then added per mL of precursor solution. ACRL-PEG-RGDS was 
added to the precursor solution so that the concentration of RGDS in the swollen 
hydrogels would be 1 μmol/g. The precursor solution then was sterilized using a 0.22 
µm PVDF filter. 3T3 cells at passage 8–9 were harvested and resuspended in the 
hydrogel precursor solution such that the post-swelling cell density would be 2 X 10
6
 
cells/mL. Each solution was poured into molds composed of two glass plates separated 
by thin polycarbonate spacers and then polymerized by 2 min exposure to longwave UV 
light (Spectroline, ~6 mW/cm
2
, 365 nm).  
 
2.2.7 Long-term 3-D Culture Experiment  
After 24 hours at 37 
o
C to allow the hydrogel to swell, an 8 mm biopsy punch 
(Miltex, York, PA) was used to cut uniform samples. Sterilized metal specimens (n=4 
per formulation) were placed in 12 well plates, and the cell samples were placed in cell 
culture inserts.(BD Falcon, San Jose, CA).  The gels and metals were immersed in 
DMEM supplemented with 10% FBS, 100 mU/mL penicillin, and 100 mg/L 
streptomycin and maintained at 37 
o
C/5% CO2. Media was collected at the 24 hour time-
point and then every 2 days for 14 days, and ICP-MS was performed at 24 hour, 7 day 
and 14 day time-points. The LDH cytotoxicity assay was performed following 14 days 
of culture.  
 
2.2.8 Long-term 3-D Experiment Analyses  
After 14-day total culture time, constructs were digested for 24 h at 37 °C in 1 ml 
of 0.1 M NaOH per 0.2 g hydrogel wet wt.
92
 The samples were then centrifuged 
(10,000g for 10 min) and aliquots were taken for DNA quantification. The aliquots of 
the hydrolyzed samples (n = 4 per formulation) were neutralized and their DNA content 
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determined using the PicoGreen assay (Invitrogen)
92
. DNA measures were translated to 
cell number using a conversion factor of 6.6 pg DNA per cell
93
. Calf thymus DNA 
(Sigma) served as a standard. 
 
2.2.9 LDH Cytotoxicity Assay 
Lactase dehydrogenase(LDH), a metabolic enzyme present in the cytosol of the 
cell, can be used to quantify cytotoxicity, as the LDH is released from lysed cells. 
Consequently, an increased level of cell death would be accompanied by an increased 
concentration of LDH in the cell media. A colorimetric LDH assay, Cytotoxicity 
Detection Kit Plus (LDH) (Roche) was used to determine LDH activity in the cell media.  
Briefly, a 1:1 ratio of cell media to reaction mixture were applied to a 96 well plate and 
allowed to react for 20 minutes at room temperature. The stop mixture was then applied 
at a 1:5 ratio to the plate and the color development was detected using a microplate 
reader. After detection, the background controls were subtracted from the experimental 
values. 
 
2.2.10 Microscopy 
Alloys were imaged using optical microscopy prior to being exposed to cell 
culture media in static conditions. Following 72 hours exposure, the alloys were rinsed 
with ethanol and imaged again. These images were compared for any signs of corrosion.  
 
2.2.11 ICP-MS  
Media collected from the cell culture study were digested with sub-boiling HNO3 
(1:3 v/v) for 6 hours at 95 
o
C. This solution was then diluted 3:4 v/v with H2O2 and 
further digested for 2 hours at 95 
o
C. Digests were then diluted 1:10 in water. Four 
standards were prepared using digested media to obtain from 0 ppb to 100 ppb Ti, Ni, 
and Nb in the final dilution. Element specific detection was then performed on the 
standards and samples using a DRC II (Perk & Elmer/Sciex) Inductively Coupled 
Plasma Mass Spectrometry (ICP-MS). The regression coefficients obtained were 
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excellent(ranging from .9996 to 1.0000). A quality control was run between every four 
samples. 
 
2.2.12 Potentiodynamic Measurements 
Potentiodynamic tests were performed on TiNb, NiTi and Ti in both Hanks‟ 
physiological solution and 1M NaCl using a Pt counter electrode and an Ag/AgCl 
reference electrode. The potential scans were performed at a constant temperature of 37 
o
C. The scan rate was 4mV/s toward the anodic direction until 2000 mV. 
 
2.3 Results and Discussion 
 
The aim of the study was to assess and compare the cytotoxicity of TiNb alloys 
for biomedical applications to more commonly used NiTi alloy and analyze the 
corrosion resistance of the TiNb alloy. The cytotoxicity of the alloys and metals was 
determined using a lactate dehydrogenase (LDH) cytotoxicity assay. LDH is a metabolic 
enzyme present in the cytosol of the cell that can be used to quantify cytotoxicity, as the 
LDH is released from lysed cells. Therefore, an increased level of cell death would be 
accompanied by an increased concentration of LDH in the cell media. The corrosion 
resistance was assessed directly using potentiodynamic measurements of the metals and 
indirectly using ICP-MS of the cell media that was cultured with the alloys and controls.  
OM imaging of the metals was also used to visually inspect the materials before and 
after exposure to cell media for the short-term experiment. 
A short term experiment was designed to put cells in direct contact with ions 
released from the metal into the cell culture media. This was a two-dimensional study 
where NIH 3T3 cells were cultured on well inserts while the alloys and control metals 
were in the same well. NIH 3T3 cells were selected because these cells are fairly 
resilient and often used for cytotoxicity assessments. Media was collected for 
cytotoxicity and ion leaching assessments every 24 hours for 3 consecutive days. The 
cells were treated with mitomycin C, which limits proliferation by blocking DNA and 
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RNA replication and protein synthesis. It is important to limit proliferation so that 
confluence is not reached by the end of the study to ensure full exposure to the ions 
produced from the alloy.  Figure 4- part A shows the cytotoxicity results, normalized 
by cell number, for the short term cytotoxicity experiment. At the 72 hour time point, the 
cells cultured with the NiTi alloy showed elevated levels of LDH indicating increased 
cell death when compared to the biologically inert Ti. The cells cultured with the Nb 
control showed a similar level of cell death to the Ti control. These controls showed 
significantly lower levels of cell death than the NiTi alloy. The TiNb alloy caused 
slightly elevated cell death when compared to the Ti control in the short term study, but 
this wasn‟t statistically significant. 
 
 
 
Figure 4: Cytotoxicity of TiNb alloy compared to NiTi, Ti, and Nb normalized by cell 
number. (A) 72 hour 2-dimensional study. *, significant difference from NiTi (B) 2 week 
3-dimensional study  
 
 *                   * 
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ICP-MS results for the short term experiment (Table 1) show an initial release of 
Ni from the NiTi alloy at 24 hours followed by a reduction in the Ni release at the 48 
hour and 72 hour time points. This initial release caused prolonged death in the Ni 
samples as the 72 hour LDH measurement for the NiTi alloy was still greater than the 
TiNb alloy and the controls. The Nb control showed high levels of Nb at the 24 hour 
time point followed by a slight reduction in the Nb release levels, but there were still 
significant reading of Nb at 48 and 72 hours. These high levels of Nb didn‟t seem to 
affect cell behavior as the Nb control didn‟t have significantly more death than the Ti or 
TiNb samples. The TiNb sample didn‟t show significant leaching of Nb into the media at 
any time point. 
 
Table 1: Ion release results for short-term experiment 
 NiTi (PPB) Nb (PPB) TiNb (PPB) 
  24 hr 48 hr 72 hr 24 hr 48 hr 72 hr 24 hr 48 hr 72 hr 
Nb ------ ------ ------ 62.8 ± 2.7 24.2 ± 0.5 22.1 ± 1.7 4.0 ±  0.4 2.5 ± 0.3 1.2 ± 0.2 
Ni 26.0 ± 3.8 3.9 ± 3.2 6.7 ± 5.1 ------ ------ ------ ------ ------ ------ 
 
 
Optical Microscopy (OM) imaging showed no signs of corrosion following the 
short term experiment even though an initial release of Ni occurred in the NiTi sample. 
Before and after OM images can be seen in Figure 5. 
 
 
 
Figure 5: Optical microscopy images of metals and alloys before and after 72 hours 
culture. Scale bar=50 μm 
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The behavior of cells is often dependent on culture conditions, as phenomena 
observed in two-dimensional culture are not necessarily observed in three dimensional 
culture. Therefore, to more closely mimic the environment in the body, a three-
dimensional study was designed with NIH 3T3 cells encapsulated in a PEGDA scaffold. 
Eight mm punches of PEGDA hydrogels were placed in well inserts and the metals were 
placed into the wells so media would be shared. Media was changed every 48 hours for 
two weeks. Figure 4-part B shows the cytotoxicity results for the long-term experiment, 
again normalized by cell number. At the 2 week time points, the cells cultured with the 
NiTi alloy and the Ni control again showed elevated levels of cell death when compared 
to the cells cultured with the Ti. Here, the Nb control showed a slight cytotoxic effect 
when compared to the Ti, but this effect was not statistically significant. The TiNb alloy 
caused a slight decrease in cytotoxicity when compared to the Ti control. Although the 
results were not statistically significant, the trends were similar in both the short and 
long-term study and the results were consistent at all of the time points analyzed.  
 
Table 2: Ion release results for long-term experiment 
 NiTi (PPB) Nb (PPB) TiNb (PPB) 
 1 wk 2 wk 1 wk 2 wk 1 wk 2 wk 
Nb ------ ------ 1.3 ± 0.2 2.2 ± 0.7 0.2 ± 0.1 4.9 ± 0.6 
Ni 2.1 ± 2.9 16.1 ± 9.04 ------ ------ ------ ------ 
 
 
Table 2 shows the ion leaching data for the long term study. At the one week and 
two week time points, the NiTi sample showed an insignificant level of Ni in the cell 
media after considering the noise in the two week time point. The amount of Nb 
leaching from the Nb and TiNb samples was also insignificant, indicating that under 
static conditions. In the NiTi samples, the ions seem to have an initial release at 24 hours 
(seen in the short-term study) followed by stabilization by 1 week. Although the levels 
of ions in the cell media wasn‟t considerable after the 24 hour time point for the NiTi 
alloy, the cytotoxicity results indicate that the effects of this initial Ni release are 
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prolonged because even at the two week time point, higher LDH levels indicate more 
cell death. 
 
 
Figure 6:  Potentiodynamic testing 
 
Potentiodynamic testing was conducted to confirm the results seen in ICP-MS 
ion leaching. Figure 6 shows the results of these corrosion tests in Hanks‟ buffered 
saline and 1 M NaCl. TiNb and Ti show similar passive corrosion behavior, while NiTi  
seems to reach a transpassive region upon anodic polarization. This indicates that Both 
Ti and TiNb exhibit superior corrosion resistance than NiTi. 
 The known toxicity of Ni has led to the controversy associated with the use of 
NiTi alloys for medical applications. Despite the presence of Ni, many researchers 
believe that NiTi alloys are biocompatible because of the corrosion resistance provided 
by a stable titanium oxide layer that limits the release of toxic Ni into the surroundings.  
Many studies that have shown NiTi to be biocompatible, yet others have raised concerns 
about cytotoxic effects and failure of NiTi devices. In both the short- and long-term 
experiments, the NiTi alloy was slightly more cytotoxic than the controls. Although the 
cytotoxicity results were not statistically significant, the trends were similar in both the 
short- and long-term study and the results were consistent at all of the time points 
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analyzed. Castleman et. al. observed in increase thickness of fibrous tissue after 
implantation in dogs. The thickness of this fibrous tissue is related to the degree of metal 
dissolution, so this indicates that metal was leaching into the surrounding tissue, 
challenging the biocompatibility of this material.
67
 This is consistent with the ion 
leaching data for NiTi which shows that Ni is leaching out of the alloy before the oxide 
layer stabilized. This effect would just worsen with loading. The TiNb alloy showed 
similar levels of cell death as the control samples, which is consistent with the 
observations by Wang and Zhang.
94
 
In addition to the lack of toxic constituents, TiNb has been shown to exhibit 
superior corrosion resistance to NiTi. Measures of corrosion through ion release and 
potentiodynamic testing showed just that. The NiTi samples showed an initial Ni release 
at the 24 hour time point before the oxide layer stabilized, while no significant level of 
Nb was measured from the TiNb alloy at any time point. Even with high levels of Nb 
leaching from the Nb control, no apparent cell death was observed, so if leaching of Nb 
from TiNb alloys occurred in dynamic conditions, it should not have a cytotoxic effect. 
It is also important to note that even with the low measured levels of Ni from the NiTi 
alloy, higher levels of LDH were measured during both experiments and this was 
repeatable. This is interesting as most literature pertaining to NiTi cytotoxicity depends 
on cell counting,
95
 morphology,
96,97
 and proliferation
98
 as the main assessments of cell 
death, but this cytotoxicity assessment showed an elevation in LDH levels indicating a 
slight increase in cell death over the controls. Although the levels of ions in the cell 
media wasn‟t considerable after the 24 hour time point for the NiTi alloy, the 
cytotoxicity results indicate that the effects of this initial Ni release are prolonged 
because at endpoints of both experiments higher LDH levels indicate more cell death. 
Many researchers have worked on improving the oxide layer on NiTi alloys to improve 
the cytotoxicity behavior,
99
 but these efforts would be compromised in dynamic 
conditions where these alloys will not only have to function in a corrosive environment 
but also under strain where the oxide layer can crack, causing higher levels on ion 
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release.
100
 When the oxide layer cracks, the reconstruction of the passive film is a slow 
and difficult process.
101
 
 Following implantation into hard tissues, which is the case in joint replacements, 
the pH decreases to approximately 5.2 and recovers to 7.4 within 2 weeks.
102
 Watari et 
al. showed that the amount of ions released from NiTi into Hanks‟ solution with pH 5 
were larger than into saline indicating that the repassivation of the NiTi alloy is 
prevented by the inorganic ions present in the Hanks solution. The phosphate ions 
become incorporated in the surface oxide in the pH 5 Hanks‟ solution which delays the 
repassivation of the material, and eventually allows for an increase in the ion release.
103
  
This could cause the passivation time to extend for NiTi alloys after implantation and 
create a weaker oxide layer.  
With improved corrosion resistance and the lack of toxic components, TiNb 
SMAs are promising replacements for NiTi.  Future research should focus on the 
behavior of TiNb alloys in dynamic conditions and studying cell ingrowth in porous 
TiNb structures.  
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CHAPTER III  
COMPOSITE HYDROGEL-ELECTROSPUN MESH SCAFFOLD 
FOR LIGAMENT TISSUE ENGINEERING* 
 
3.1 Introduction 
 
More than 150,000 ACL reconstruction surgeries are performed each year in the 
United States,
2
 mostly in young, active individuals. Ligaments are dense fibrous tissue 
bands which connect two or more bones, guide joints through their normal range of 
motion, and maintain joint stability. Injury to these ligaments can range from minor 
disruption to the normal structure, to complete rupture of the tissue. This damage can 
result in pain and joint instability and eventually disease. The capacity for ligament 
tissue to recover from injury depends on many factors including location, mechanical 
forces they must withstand, and blood supply. Ligaments outside of joints, such as the 
medial collateral ligament will normally heal naturally
104
 but ligaments that are within a 
joint, like the ACL, do not heal properly after damage because of limited vascularization 
and poor clotting ability.
104-106
 Multiple treatment options exist for tears, but for ruptures, 
surgery is the primary option.
106
 Figure 7 shows the ACL during knee flexion, tension, 
and hyperextension.
107
 In a study by Feagin, et al., both ends of ruptured ACLs were 
sutured together but after 5 years, were still not effectively fused and 94% of patients 
suffered from knee instability, demonstrating the limited healing potential of the ACL.
106
 
Therefore, the current treatment for rupture includes surgical removal of the ACL and 
replacement with a graft that is fixed to the bone on both ends.
108,109
  
 
 
 
 
________________ 
*Part of this chapter is reprinted with permission from “Hydrogel-Electrospun Mesh Composites for 
Coronary Artery Bypass Grafts” by McMahon RE, Qu X, Jimenez-Vergara AC, Bashur CA, Guelcher SA, 
Goldstein AS, Hahn MS, (in press) Tissue Engineering Part C. Copyright (2011) by Liebert Publishing 
Company  
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Figure 7: Bundles of the ACL. A) during knee flexion, B)during knee extension the ACL 
is taught, C) upon severe knee hyperextension, the ACL is torn by the femur 
107
 
 
 The treatment for ligament damage generally includes surgery as more 
conservative treatments are often unsuccessful. The surgical treatment options include 
autografts, allografts, and synthetic grafts. Autografts are currently considered to be the 
best option. The quadriceps tendon or patellar tendon are often used for the 
autograft.
110,111
 These risk the pain and donor site morbidity, which can cause muscle 
atrophy and tendonitis.
112,113
 Allografts are limited by the availability of donor tissue, the 
risk of disease transmission,
114
 and the potential for the tissue damage during storage.  
An immune response can occur in response to foreign proteins or cells in an allogenic 
graft which can trigger tissue rejection.
115
  Dacron, Gore-Tex, and polypropylene based 
grafts which are non-biodegradable, have been developed but are currently not approved 
for ACL replacement because of low success rates, between 30 and 60%.
116
 
 Tissue engineering is a potential fourth option. A tissue engineering approach 
combines a biodegradable scaffold with autologous cells, such as mesenchymal stem 
cells that can differentiate into ligament fibroblasts and then induce tissue formation 
though the deposition of ECM.
117,118
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Figure 8: Ligament behavior under tensile load
119
 
 
Native ligament exhibits three different regions of its stress-strain curve (the 
“toe-in” region, the linear region, and the yield region) during loading (Figure 8).119 The 
crimped pattern of the collagen fibrils are straightened and elongated upon introduction 
of strain which creates the “toe-in” region.113 After 2-4% strain the fibrils are elongated 
and stretching of the collagen triple helices and intrafibrillar slippage between crosslinks 
occurs causing the linear region.
119-121
 The failure of ligament tissue generally occurs 
between 7 to 16% strain. During normal movement, the ACL is typically stretched 4-
5%, through the “toe-in” region and part of the linear region122 and the typical ACL is 
able to withstand the loads associated with normal activity because it has a modulus of 
about 111 MPa.  
 Electospun meshes have been identified as a potential scaffold for tissue 
engineering of ligaments as they can possess the high tensile properties necessary for 
replacing ligament. Electrospinning is a common method for fabricating fibrous non-
woven meshes with high tensile strength and open porous structures.
123
 Electrospun 
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fibers can be oriented by electrospinning onto a rotating drum
124
 and the fiber diameters 
produced in the range of 100 nm to 7 um.
125-128
  Oriented meshes have the ability to 
align cells through a phenomenon called contact guidance and these oriented cells will 
deposit oriented ECM.
129-131
 This is important because oriented ECM has higher tensile 
strength than unoriented ECM like scar tissue.
132
  Mesh thickness is controlled primarily 
by the length of time for electrospinning and typically ranges from 140 um to .5 mm.
133-
135
 Thicker scaffolds can be produced, but this isn‟t practical because producing a 
thickness of 1 mm requires many hours of electrospinning.
136
  Therefore, a scaffold that 
maintains high tensile strength of electrospun scaffolds while bringing the thickness of 
the constructs nearer to that of native ligament would be desired. 
One possible approach to achieving these dual design goals is to form a 
composite consisting of electrospun fiber mesh layers bonded together by a hydrogel 
matrix. Hydrogels generally have initial tensile moduli and strengths significantly below 
those of native ligament.
137
 Therefore, the composite scaffold would be expected to have 
mechanical properties intermediate between that of the electrospun layers and the 
hydrogel adhesive. In the present work, we validated this approach by using a poly(ester 
urethane) urea (PEUUR)-based electrospun mesh and a poly(ethylene glycol) (PEG)-
modified fibrin hydrogel. PEUURs are a family of biodegradable, biocompatible, 
elastomers
138,139
 with mechanical properties (i.e., elastic modulus, strain to failure, 
ultimate tensile strength, and degradation rate) that can be varied over a broad range by 
careful control of the chemistry and molecular weight (Mw) of the individual PEUUR 
segments.
138,140,141
 Concurrently, fibrin gels are known to be adhesive
142
 and appear to 
support the elastogenesis important to the maintenance of long-term graft mechanical 
properties.
143
 Further, the grafting of PEG chains to these hydrogel networks slows their 
degradation,
144
 reduces their thrombogenicity,
145
 and can enhance their initial 
mechanical properties. In the current study, we demonstrate that fibrin gel-PEUUR mesh 
composites can be fabricated with circumferential moduli and tensile strengths in the 
range of native vasculature. In addition, we show that the resulting constructs support 
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extracellular matrix (ECM) accumulation and maintain their mechanical integrity 
following prolonged cyclic stretching.  
 
3.2 Materials and Methods 
 
3.2.1 Polyurethane Synthesis  
 A linear segmented degradable PEUUR elastomer, consisting of alternating a PCL 
soft segment and a urethane- and urea-containing hard segment, was synthesized using a 
standard two-step technique in a three-neck, round-bottom ﬂask equipped with argon 
inlet and outlet, condenser, and stirrer.
146
 First, the ﬂask was charged with anhydrous 
dimethyl sulfoxide (DMSO, <50 ppm water; Acros Organics) and 1,6-
diisocyanatohexane (HDI; Sigma-Aldrich), immersed in a 75 
o
C oil bath, purged with 
argon, and constantly stirred. Next, PCL diol (average molecular weight 2000 Da, 
PCL2000; Sigma,) that had been dried for 24 h at 80 °C under vacuum (10 mmHg) and 
dissolved in DMSO was charged into the reactor by means of an addition funnel. The 
prepolymer content in the reactor was controlled at 14 wt%, and the relative masses of 
HDI and PCL2000 were selected to achieve a prepolymer NCO:OH equivalent ratio of 
2.0:1.0. Dibutyltin dilaurate (Sigma) was added to the ﬂask at 1000 ppm, and the 
reaction was allowed to proceed for 3 h to produce a HDI.PCL2000.HDI prepolymer. In 
the second step, a solution of 1,3-propanediol bis(4-aminobenzoate) (Sigma-Aldrich) in 
DMSO was prepared at 50
 
°C and added to the resultant prepolymer in the reaction 
vessel. The NCO:OH equivalent ratio of the polyurethane was controlled at 1.03:1.0, and 
the polymer concentration was 12 wt%. Dibutyltin dilaurate was added to a 
concentration of 1000 ppm. The reaction was allowed to proceed at 80
o
C for 20 h. The 
ﬁnal polymer was then precipitated in diethyl ether (Sigma) and dried for 24 h at 8 °C 
under vacuum. 
 
3.2.2 Electrospinning Procedure 
 The PEUUR was electrospun to form fused-ﬁber meshes with controlled ﬁber 
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diameter and ﬁber alignment as described previously.147,148 Brieﬂy, electrospinning was 
performed with a 10 wt% PEUUR2000 solution in 50:50 isopropanol:1,1,1,3,3,3-
hexaﬂouro-2-propanol (HFIP; Sigma) using a 22-gauge Teﬂon tipped needle, a 15 kV 
potential, a throw distance of 15 cm, and a syringe ﬂow rate of 5 mL/h. A 6-cm-diameter 
drum rotating at a linear velocity of 8 m/s served as the collector. Meshes (150-200 µm 
thickness) were removed from the drum and soaked in ethanol for 7 days followed by 
deionized water for 2 days to remove residual HFIP. The meshes were then dried and 
stored in a desiccator until use. The meshes were sterilized by γ-irradiation at the Wake 
Forest Institute for Regenerative Medicine. 
 
3.2.3 Mechanical Testing of Electrospun Mesh 
The tensile moduli of electrospun PEUUR meshes were determined using 
15×10 mm strips that had been soaked in PBS overnight before testing. The thickness of 
the meshes was on the order of 0.1-0.2 mm and therefore could not be accurately 
measured with calipers. Instead thickness was estimated from measurements of mesh 
mass, length, width and density (1.13 g/cm
3
) using an assumed porosity of 60%
133
.
 
The 
segments were exposed to uniaxial strain at a rate of 6 mm/min until failure. Modulus 
was calculated from the linear region of the stress strain curve (typically between 25 and 
45% strain) using a cross-sectional area based on an assumed 60% mesh porosity. 
Results are presented as mean ± standard deviation for n=3 meshes. 
 
3.2.4 Scanning Electron Microscopy 
The mean fiber diameter and angular deviation were determined to by 
quantitative analysis of SEM images per Bashur et al.
149
 Briefly, electrospun meshes 
were mounted onto studs and sputtercoated with a 10nm layer of palladium (Model 
208HR, Cressington Scientific Instruments,). Images were acquired using a LEO 1550 
Field Emission SEM (Carl Zeiss SMT) operating at 5kV with a 16mm working distance. 
Resultant images were imported into ImagePro Plus software (ICube,) for analysis of 
fiber diameter and fiber orientation. Fiber diameter and angle of orientation (relative to 
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the vertical axis of the image) was determined manually. The degree of orientation was 
characterized by the angular standard deviation, σ, for a wrapped normal distribution: 
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Here, the probability distribution function has been adapted from Fisher
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 for a 
periodicity of π radians, where μ is the mean angle and ρ is the mean resultant length. 
These parameters were determined from a set of n measured fiber orientations, θi, by the 
following equations: 
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Finally, the angular standard deviation was calculated from the mean resultant length: 
 ln2
2
1
 . 
 
3.2.5 Poly(ethylene glycol) Diacrylate Synthesis 
 Diacrylate-derivatized PEG (PEGDA) was prepared as previously described
91
 by 
combining 0.1 mmol/mL dry PEG (3.4 kDa; Sigma), 0.4 mmol/mL acryloyl chloride, 
and 0.2 mmol/mL triethylamine in anhydrous dichloromethane (DCM; Fisher Scientific) 
and stirring at 4 °C under argon overnight. The resulting solution was washed with 2 M 
K2CO3 and separated into aqueous and DCM phases to remove HCl. The DCM phase 
was subsequently dried with anhydrous MgSO4, and PEGDA was precipitated in diethyl 
ether, filtered, and dried under vacuum. 
 
3.2.6 Cell Culture 
 Mouse smooth muscle progenitor cells (10T½, American Type Culture 
Collection) at passage 2 were thawed and expanded at 37 °C and 5% CO2. During 
expansion, cells were cultured in Dulbecco‟s Modified Eagle‟s medium (DMEM; 
Hyclone) containing 10% heat-inactivated fetal bovine serum (FBS; Hyclone). Cells 
were harvested for seeding and/or encapsulation between passages 10 and 12. 
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3.2.7 Construct Fabrication 
 To fabricate cylindrical constructs, molds consisting of a Teflon base, an inner 
hollow latex tube (0.125” OD, 0.015” wall thickness; Kent Elastomers) supported by a 2 
mm glass rod, and an outer hollow cylinder of Teflon (0.25” ID, 0.012” wall thickness; 
Small Parts, Inc.) were used.  All mold components were sterilized by autoclaving. Latex 
tubing was used as an inner mandrel of the mold per Syedain et al.
151
 to aid in the 
formation of a tight-seal when mounting of the constructs on bioreactor ports. Each 
construct was fabricated in a two-step process, the first involving fibrin gel-mesh 
preparation and the second involving PEG grafting to the fibrin component of the 
resulting constructs. 
 
3.2.8 Fabrication of PEG Grafted Fibrin-Mesh Composites  
 Rectangular segments (2 cm × 3.5 cm) were cut parallel to the direction of fiber 
orientation from the 150-200 µm thick mesh. Next, each mesh segment was exposed to 
media containing 40% serum overnight at room temperature to improve cell adhesion. 
The coated mesh segments were then rinsed with PBS, and cells were seeded on the 
upper mesh surface at 10
4
 cells/cm
2
. Following two days of culture, the cell-laden 
meshes were rolled around the latex mandrels (Figure 9- part A), resulting in 2 to 3 
layers of mesh and a mean circumferential orientation of the mesh fibers. During the 
rolling processes, the cell layer faced outward and mesh segments were handled only at 
the edges to limit mechanical removal of seeded cells. A sterile 3.1 wt% fibrinogen 
solution containing 5 U/ml thrombin and 5x10
6 
10T½ cells per mL was then prepared 
and pipetted around the inner mesh-wrapped mandrel. This fibrinogen solution 
impregnated the layers of rolled mesh as it polymerized, resulting in a cohesive fibrin 
gel-electrospun mesh composite. Following 30 minutes incubation at room temperature, 
the constructs were removed from the molds and immersed in PBS containing 1.3 U/mL 
thrombin, 0.5 wt% 3.4 kDa PEGDA, and 0.26% Irgacure 2959. After 1 hour at 37 °C, 
the constructs were removed from the solution, and exposed to longwave UV light (~10 
mW/cm
2
, UVP) for 5 minutes. The purpose of this extended thrombin exposure followed 
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by vinyl-mediated PEG grafting was to slow the rate of fibrin degradation through 
increased fibrin crosslinking (achieved through additional exposure to thrombin). In 
addition, conjugation of PEG chains to proteins has been demonstrated to reduce the rate 
of protein degradation
144
 and to decrease thrombogenicity.
145
 PEGDA was not added to 
the initial fibrinogen solution, since it tended to induce irregular clotting of the 
fibrinogen on addition of thrombin. The PEG-grafted fibrin-mesh composite (PEG-FB-
mesh) constructs (~15 mm length, ~5.5 mm O.D., ~1mm thickness) were then immersed 
in media containing 10% FBS and 1% PSA (10,000 U/mL penicillin, 10 g/L 
streptomycin, and 25 mg/L amphotericin, Mediatech). 
 
3.2.9 Cell Viability Analysis  
To confirm the cytocompatibility of the extended thrombin-PEGDA exposure 
associated with hybrid gel-mesh construct fabrication, LIVE-DEAD staining 
(Invitrogen) was performed per standard protocols for n = 3 specimens. 
 
3.2.10 SEM Analysis of Composites 
To examine the interpenetration of the fibrin gel and electrospun mesh 
components of the composite constructs, ring segments were fixed in 10% acrolein 
(Sigma) and dehydrated with a graded ethanol series (5-100%) with intermittent vacuum 
in a PELCO Biowave microwave system (Ted Pella, Inc.) at 200 W and 10 C.  One 
min microwave cycles were used for dehydration until 50% ethanol, after which 6 min 
cycles were used to complete the dehydration process. Final dehydration consisted of 
three changes of 100% ethanol with intermittent vacuum and 6 min microwave cycles. 
Ethanol was then replaced with three changes of hexamethyldisilizane (Electron 
Microscopy Sciences) followed by the intermittent vacuum and microwave cycles. The 
resulting ring segments were mounted along their base onto stubs, after which they were 
exposed to ruthenium tetroxide vapor (Sigma), sputtercoated with Au:Pd (60:40), and 
imaged in a JEOL 6400 SEM equipped with a tungsten filament at an accelerating 
voltage of 10 kV. 
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3.2.11 Construct Integrity Following Mechanical Conditioning 
 After two days static culture, 1 ng/ml transforming growth factor 1 (TGF-1; 
Sigma) was added to the culture media to promote 10T½ differentiation into smooth 
muscle like-cells.
147
 Following a total of 4 days of static culture, each construct was cut 
in half using surgical scissors. One half of each construct was randomly assigned for 
dynamic culture (n = 4), while the remaining portion was allocated for static culture (n = 
4). Dynamic constructs were mounted in a modification of the pulsatile flow bioreactor 
previously described in Bulick et al.
137
 Because bioreactors are expensive to design and 
must be validated, the constructs were mounted on a bioreactor designed for vascular 
grafts. The electrospun mesh fibers were oriented in the direction of the strain 
(circumferentially) and experienced a 2% strain for 12 days. 
 During the period of mechanical conditioning, both static and dynamic constructs 
were cultured in DMEM, 10% FBS, 1% PSA, 1 ng/mL TGF-1, with 2 mg/mL ε-
aminocaproic acid to slow the degradation of the fibrin, and 50 µg/ml ascorbic acid 
added to increase collagen production.  Media was changed for all constructs every two 
days for 12 days.   
 
3.2.12 Construct Analyses 
 After 16 days total culture time, the static and dynamic constructs were harvested 
for biochemical and histological analyses. Each PEG-fibrin-mesh construct was cut into 
5 ring segments, each ~3-5 mm in length, and the latex tubing was gently removed. The 
two end-segments were discarded. One segment per construct was allocated for 
mechanical testing. The remaining sections were immersed in formalin overnight, after 
which they were allocated for histological or biochemical assays.  Details of the 
mechanical testing, and biochemical and histological analyses are given in the following 
sections. 
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3.2.13 Mechanical Property Assessment 
 The mechanical properties of the hydrogel-mesh composites were measured at 
time zero and following 16 days of culture. For mechanical property assessments, 3-5 
mm ring segments were cut using surgical scissors from constructs that had been 
immersed in media overnight. Circumferential mechanical tests were performed using a 
modiﬁcation of the technique validated in Johnson et al.91 Calipers were used to measure 
the dimensions of each construct segment. Each ring was then mounted onto an Instron 
3342 equipped with a 10 N load cell using custom brackets.
137
 The ring segments were 
exposed to uniaxial strain at a rate of 6 mm/min until failure. Applied stress was 
calculated from the measured force by approximating the area of force application as 
two rectangles, each with sides equal to the width and wall thickness of the ring. The 
gauge length, lg, was taken as the inner diameter, Dv, of the unstretched ring plus the 
wall thickness, hv. The incremental or tangential modulus, E, of each sample was defined 
as the slope of the resulting stress–strain curve at a reference stress of 20 kPa to mimic 
the circumferential stress experienced by vessels under physiological pressures (~0.5 
Pavg Dv /hv ).
152
 The ultimate tensile strength (UTS) of the samples was defined as the 
maximum stress applied prior to failure. 
 
3.2.14 Biochemical Analyses 
 Samples for biochemical analyses were transferred to 2 mL screw-cap microfuge 
tubes containing 1.5 ml of lysis buffer (PBS containing 1% Triton X-100 (Fisher), 0.5% 
sodium dodecyl sulfate (Sigma), and 100 µg/mL phenylmethanesulfonylfluoride 
(Sigma)) and 1 mL of 3.2 mm stainless steel beads. Each sample segment was 
homogenized at 4800 rpm in a Bead-Beater homogenizer (Biospec) in 10 s cycles with 1 
min intermediate cooling on ice. Each sample was analyzed via competitive ELISA for 
(ECM) proteins collagen I (COL1A1; clone D-13) and collagen III (COL3A1; clone S-
17) and housekeeping protein GAPDH (clone V-18). In brief, peptides corresponding to 
the immunogen for each antibody were obtained from Santa Cruz Biotechnology 
(SCBT) and used to coat EIA plates (Costar) at either 500 ng (collagen III peptides) or 
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2000 ng (collagen I and GAPDH peptides) per well, after which the wells were blocked 
with bovine serum albumin (BSA). At the time of analysis, samples were incubated with 
primary antibody (SCBT) for 1 h, after which the sample-antibody mixtures were 
applied to the coated plates for 1 h. Standards were prepared by similarly incubating 
primary antibody with varying levels of immunogen peptide for 1 h, followed by 
application to coated plates. For both samples and standards, bound primary antibody 
was detected using an appropriate HRP-conjugated secondary antibody (Jackson 
Immunoresearch), followed by application of 2,2'-azino-bis(3-ethylbenzthiazoline-6-
sulphonic acid) (Sigma) and monitoring of absorbance at 410 nm. 
 
3.2.15 Histological Analyses 
 Histological sections were fixed in formalin overnight at 4 °C, embedded in OCT 
media, and cut into 10 μm sections using a CryoJane Tape Transfer system 
(Instrumedics). This system allowed the sections to be anchored to the slide to retain 
construct structural integrity during the immunostaining process. ECM deposition and 
cell phenotype were analyzed in 2 sections per sample using standard 
immunohistochemical techniques. In brief, rehydrated sections were blocked by 30 min 
exposure to Terminator (Biocare Medical). Primary antibodies for elastin (BA-4; 
Sigma), collagen I (Rockland Immunochemicals), collagen III (Rockland 
Immunochemicals) were diluted in PBS containing 3 % BSA and 0.5 % Tween 20 and 
applied overnight at 4 °C. Bound primary antibody was detected either by using the 
appropriate HRP-conjugated secondary antibody (Jackson Immunoresearch) followed by 
application of the chromogen 3,3‟-Diaminobenzidine (DAB; SCBT). Sections were then 
dehydrated with graded alcohol followed by xylene, and then mounted using Polymount 
(Polysciences) or Curemount (Instrumedics). Stained sections were imaged using an 
Axiovert microscope (Zeiss). 
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3.2.16  Statistical Analyses 
 Data are reported as mean ± standard error of the mean. Comparison of sample 
means was performed by one-way ANOVA, p < 0.05. 
 
 
3.3 Results and Discussion 
 
Composite hydrogel-electrospun mesh scaffolds were generated by rolling a 
PEUUR electrospun mesh around an inner mandrel and then binding the juxtaposed 
layers together using a fibrin-based hydrogel. Mouse mesenchymal progenitor cells, 
10T1/2, which have the ability to differentiate into ligament fibroblasts, were seeded 
onto the electrospun mesh 4 days before rolling and suspended in the fibrin hydrogel to 
ensure even distribution throughout the construct. This process resulted in a cylindrical 
construct with multiple layers of electrospun mesh and hydrogel between and 
throughout, as seen in Figure 9. After 16 days total culture time, mechanical testing was 
performed and biochemical and histological analyses were completed to determine the 
feasibility of this composite system as a tissue engineered ligament graft. 
 
 
 
Figure 9: Construct fabrication. (A)A wetted electrospun mesh wrapped around the latex 
mandrel of a construct mold. An outer thin walled PTFE hollow cylinder was then placed 
around the wrapped mandrel. After fibrinogen-thrombin solution was pipetted into the 
mold and allowed to set, a hydrogel-mesh hybrid construct resulted. (B) Resultant layered 
hydrogel-electrospun mesh structure. Scale bar  = 5 mm. 
 38 
Fluorescence imaging was used to confirm the ability of acrylate (ACRL)-
terminated PEG to graft to fibrin hydrogel networks. A monoacrylate-derivatized PEG 
molecule (ACRL-PEG-lysine) was prepared for these assays. Conjugation of the PEG 
to lysine permitted the introduction of a fluorescent label using standard NHS 
chemistry.  The intensity of the fluorescence in Figure 10- part C is much higher than 
the controls (Figure 10-parts A and B), indicating that the (ACRL)-terminated PEG 
did in fact have the ability to graft to the fibrin networks. 
 
 
Figure 10: Confirmation of the ability of acrylate (ACRL)-terminated PEG to graft to 
fibrin hydrogel networks. All images were obtained using the FITC fluorescence channel 
of a Zeiss Axiovert microscope. (A) A representative image of a pure fibrin gel. (B) A 
representative image of a fibrin gel exposed to photoinitiator and longwave UV light but 
not to AlexaFluor 488-labeled ACRL-PEG-lysine. (C) A representative image of a fibrin 
gel exposed to photoinitiator and 0.5 wt% AlexaFluor 488-labeled ACRL-PEG-lysine 
followed by longwave UV light. The hydrogels in (B) and (C) were immersed in PBS 
overnight followed by several rinses in PBS prior to imaging to ensure removal of 
unconjugated species. The scale bar in (A) applies to all images and represents 50 µm. 
  
In addition to providing the “toe-in” region associated with the composite 
scaffold, the PEG-fibrin hydrogel was intended to act as an adhesive agent, effectively 
bonding successive mesh layers together. To serve as an effective bonding agent, the 
fibrin hydrogel should penetrate into the electrospun mesh layers. SEM imaging was 
therefore conducted to assess the microstructure of the PEG-FB-mesh composites. The 
resulting images indicate that the chosen construct fabrication conditions supported the 
hydrogel-mesh interpenetration required for construct integrity and for the effective 
transfer of load between scaffold components (Figure 11- parts B-C). To confirm the 
cytocompatibility of the extended exposure to thrombin, PEGDA, and photoinitiator 
associated with construct generation, the LIVE-DEAD assay was performed on scaffold 
segments (Figure 11– part D). These studies indicated a 24 h post-fabrication cell 
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viability of 75 ± 2%, a level consistent with that observed following cell encapsulation 
within PEGDA gels.
153
 
 
 
Figure 11: Construct structural integrity and cell viability. (A) An SEM image of a single 
electrospun mesh layer illustrating fiber thickness and orientation. (B) An SEM image of 
a transverse cross-section through a hydrogel-electrospun mesh construct indicating 
effective bonding and interpenetration between the hydrogel and mesh layers. In 
preparation for SEM imaging, the inter-layer bond withstood dehydration (which 
differentially impacts hydrogel and mesh components) as well as multiple microwave 
cycles. (C) A higher magnification image of the boxed region of the hydrogel-mesh 
construct shown in (B). (D) A representative fluorescence image of LIVE (green)-DEAD 
(red) stained cells within the fibrin gel portion of the hybrid constructs at 24 h post-
fabrication. As shown in (D), cells encapsulated within the fibrin hydrogel had not yet 
fully spread following 24 h of culture. The scale bars in (A)-(C) represent 10 µm and the 
scale bar in (D) represents 40 µm. 
 
To determine the shape of the stress-strain curve of the composite scaffold, 
tensile testing in the direction of the fibers was performed at time zero and following 16 
days total culture.  Figure 12- part A shows a typical stress-strain curve for tensile 
testing on PEG-FB-mesh composite scaffold following 14 days of static culture. There is 
a “toe in” region, followed by a linear region, and then the onset of failure, similar to the 
ligament. Figure 12- part B compares this behavior to that of pure electrospun ring 
sample. The pure electrospun mesh scaffold did not exhibit a “toe-in” region as seen in 
typical ligament tissue. Therefore, the composite scaffold seems to exhibit behavior of 
both components of the scaffold creating a scaffold with properties which better mimic 
native ligament. 
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Figure 12: Mechanical testing. (A) A representative ring test of a PEG-fibrin-mesh 
construct following 14 days of static culture (B) A representative time 0 PEG-fibrin-mesh 
composite scaffold compared to a time 0 pure mesh ring 
 
 
In order to examine cell phenotype and ECM production, competitive ELISA 
assays and immunohistology were performed on PEG-FB-mesh composites. Since the 
ECM of the ligament is mainly composed of collagen I and collagen III, as well as 
elastin, these ECM markers were examined. Contrary to expectations, COL1A1 and 
COL3A1 appeared unchanged by mechanical conditioning when analyzed using 
competitive ELISA (Figure 13- part A). Both collagen I and collagen III would be 
expected to be elevated in mechanical conditioned constructs.
92,148,151,154
 However, 
elastin deposition appeared to increase with mechanical conditioning, although this trend 
fell below statistical significance. Increased elastin production
92,148,151,154
 is generally 
associated with cyclic distension. Histology supported the trends for ECM production 
(Fig 13- part B) and these proteins were able to diffuse through and deposit into the 
mesh.  
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Figure 13: Immunostaining and biochemical comparison of static and mechanically 
conditioned PEG-fibrin-mesh constructs. (A) ELISA results for COL1A1, COL3A1, 
elastin per unit GAPDH. (B) Representative images of collagen type III and collagen type 
I immunostained sections. The scale bar applies to all images and represents 50 µm. 
 
 
For hydrogel-mesh composites to maintain appropriate mechanical properties 
over the long-term, however, the loss of construct stiffness and strength due to mesh 
and/or fibrin degradation or to the hydrogel-mesh bond must be offset by neomatrix 
production. Ideally, the cells and deposited matrix will be distributed throughout the 
scaffold. Immunostaining for collagen I and collagen III (Figure 13- part B) showed 
protein deposition in the meshes with a higher concentration near the edges of the gel as 
indicated by darker staining. This is a good indication that more cells are located toward 
the edges of the meshes but they can deposit proteins further into the scaffold. 
The tensile modulus of the oriented PEUUR electrospun mesh used herein 
parallel to the fiber orientation was approximately 690 kPa, which is much lower than 
the 111 MPa modulus of native ligament. The initial circumferential modulus was 
determined to be 314 ± 17 kPa, and was unchanged following 16 days total of either 
static or dynamic culture.  Although these properties would not be suitable for use in 
ligament tissue engineering, this method produced a graft which could withstand 
prolonged cyclic stretching and had dimensions suitable for implantation. Since both the 
mechanical properties of the electrospun mesh and fibrin gel can be broadly tuned, we 
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anticipate that the tuning of the scaffold formulation will result in a composite graft 
which better matches desired graft properties. For example, Huang et al. developed a 
method to electrospin a synthetic sequence of elastin that resulted in a dried nanofiber 
mesh with a Young‟s modulus of 1.8 GPa.155 The current research shows that the 
mechanical properties of the electrospun mesh can be modulated by fabricating a 
composite scaffold with a hydrogel, so selection of the electrospun component with a 
higher tensile strength could produce a scaffold with mechanical properties suitable for 
implantation, yet retaining the other benefits from the design on the composite scaffold. 
Mechanical testing of PEG-FB-mesh scaffolds suggests that the mechanical 
integrity of these constructs is robust under both prolonged static culture and 
physiological pulsation. However, the variance in the observed moduli and UTS among 
samples within a given treatment group increased notably with culture in both static and 
dynamic culture. In addition, cyclic pulsation appeared to be resulting in a more rapid 
reduction in the UTS relative to static culture, although this trend was not statistically 
significant.  The properties of the composite scaffolds seem to be highly correlated with 
the integrity of the fibrin glue bond between each adjacent mesh layer. The integrity of 
this fibrin bond can be reduced by fibrin or mesh degradation and/or mechanical 
shearing. Thus, if dynamic conditioning is indeed resulting in a reduction in UTS, the 
mechanical shear between bonded fibrin-mesh layers induced by repeated distension 
may underlie this reduction. 
This project showed the feasibility of composite electrospun mesh-hydrogel 
composites for tissue engineered ligament grafts. These composite systems warrant 
further study as they can be applied for regeneration of not only ligament, but many 
other oriented tissues such as vascular or neural. 
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CHAPTER IV 
COMPOSITE EXTRACELLULAR MATRIX-ELECTROSPUN MESH  
SCAFFOLD FOR LIGAMENT TISSUE ENGINEERING 
 
4.1 Introduction 
 
 Recently, in order to try to use the ECM produced by cells as the main scaffold 
for tissue engineering and to bypass the drawbacks associated with traditional scaffolds, 
researchers have been trying to apply cell sheets for ligament
156
 tissue engineering. Most 
tissue engineering approaches involve culturing cells on tissue culture plastic until the 
necessary number is obtained, followed by enzymatic digestion (trypsin) to prepare a 
suspension of single cells. These cells are encapsulated or seeded onto a scaffold. The 
disadvantage to this method includes the loss of many cells during the process of seeding 
onto scaffolds as many cells do not adhere to the scaffold, but seep through the pores.
157-
159
  The cells that do adhere must then produce new ECM, and the loss of cellular 
activity due to changes in chemical makeup and morphology of cells may be attributed 
to trypsinization.
160
 
 Researchers have successfully layered multiple two-dimensional sheets of adult 
cells to create a three dimensional tissue.
161-163
 but these cells have limited lifespan, 
differentiation potential, and require long culture times to produce a cell sheet with ECM 
strong enough to be handled. Mesenchymal stem cells have the capability of 
differentiating toward ligament cells,
120
 and have better collagen secretion and 
proliferative capacity than mature collateral ligament, ACL, and skin fibroblasts.
164,165
 
Sheets of bone-marrow derived MSC were grown and shown to be viable and produce 
collagen I, collagen III, and tenacin-C
156
 showing ligament differentiation potential.
166
 
 Much of the tensile strength of ligament tissue comes from the structure of 
parallel collagen bundles. The idea of cell sheets for tissue engineering neglects this 
important design consideration, so the organization of the ECM may be different from 
that in natural tissue. A biodegradable oriented scaffold, such as an aligned electrospun 
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mesh may provide the guidance the cells and their ECM need to produce this aligned 
structure.  
 Cells can attach to ECM proteins on a scaffold–either present in natural 
biomaterials or after proteins from the cell growth media are adsorbed onto a synthetic 
surface –through integrins adhesion receptors. Integrins are trans-membrane proteins and 
the outer part recognizes a binding site on ECM proteins. On the inside of the cell, the 
integrins attach to the actin filaments, and the organization of the actin depends on the 
mechanical properties of the scaffold, by increasing organization with increased 
mechanical properties.  
 In 1945, the phenomenon of contact guidance was first discovered when cells 
were found to align with fibrin.
167
 This behavior has since been observed with several 
types of cells (macrophages, fibroblasts, neurons) on many surfaces including metals, 
silicones, and polymethylmethacrylates
168
 indicating that this is a generalized cell 
phenomenon. Oriented cells will also deposit oriented ECM.
129,130,169
  
Studies performed on microgrooved surfaces have given insight on contact 
guidance. Groove width and depth have been shown to affect cell behavior. With equal 
width grooves between 2 and 10 m, fibroblasts orientation was found to increase with 
decreased groove spacing.
170,171
 The time required for fibroblasts to orient was also 
decreased on a 1 m repeating groove structure as compared to other conditions,172 
indicating that smaller features have more effect on cell alignment. In a study on axon 
behavior, nanoscale grooves were shown to orient cells, but 100 nm surface features 
were too  small for axons to sense, while they were guided by structures of 200 nm and 
larger.
173,174
 The ideal feature size for ligament tissue engineering cells (MSC or 
ligament fibroblasts) may be able to be optimized for design of grafts.  
Although fibrous meshes differ from grooved surfaces in several respects, they 
have also been shown to induce contact guidance. For these meshes, the fibers are round, 
rather than the straight walls on the grooved surfaces. Electrospun meshes are also a 
three-dimensional scaffold, where the orientation of the fibers may vary throughout the 
mesh. The thin fibers in electrospun meshes may be able to be deformed by cells. The 
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fiber diameter and alignment of the meshes, which control cell attachment and 
spreading, can be controlled by varying polymer concentration, molecular weight, and 
rotation speed of the collection drum.  
Although electrospun meshes are a more complex system than the simple 
repeating groove structures, Lee et al found higher collagen expression from human 
ligament fibroblasts cultured on aligned fibers than those cultured on randomly oriented 
meshes.
175
 Bashur et al found that NIH 3T3 fibroblasts cells adhered to and proliferated 
well on all PLGA meshed formed with varying fiber diameters (0.14 – 3.6 m) and 
degrees of fiber orientation (32-60
o
). Cells were able to align with the fibers of the mesh 
with increasing fiber diameter and increasing fiber orientation, indicating that with 
proper design considerations, electrospun meshes may be suitable for tissue engineered 
ligament scaffolds.
176
 In another study by Bashur et al, rat bone marrow stromal cells 
express higher levels of ligament proteins with smaller fiber diameter PEUUR meshes, 
and there is a higher degree of alignment and elongation of cells with more alignment in 
the mesh fibers,
149
 indicating that each scaffold system has to be optimized before 
application. 
To further probe the use of electrospun mesh as a tissue engineered ligament 
graft, an experiment was designed comparing two methods for fabrication of a tissue 
engineered ligament graft, using only the ECM that cells produce to seal layers of 
electrospun mesh. The electrospun mesh was composed of poly(ester-urethane urea) 
(PEUUR), an elastomeric biomaterial that is capable of undergoing repetitive stretch in 
vitro, so may be able to be applied as a ligament tissue engineered scaffold. A cylindrical 
construct was fabricated using a rolling method to produce a scaffold with multiple 
layers of electrospun mesh with cells in-between these layers. The total culture time was 
6 weeks for both fabrication methods, but the time before rolling varied. In the first 
method, cells were seeded onto the mesh and then cultured for four weeks. The mesh 
was then rolled to create a cylindrical structure, and then cultured for 2 more weeks. In 
the second fabrication method cells were cultured on the mesh for 2 weeks prior to 
rolling, and then four weeks as a cylindrical construct.  The construct mechanical 
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properties and protein deposition of the two fabrication methods were compared. It was 
hypothesized that the method with longer culture time after rolling would produce a 
stronger graft. 
 
4.2 Materials and Methods 
 
4.2.1 Construct Fabrication and Initial Evaluation 
 Meshes were treated with DMEM containing 40% FBS overnight. The following 
day, meshes were rinsed with PBS and cells were seeded at 10,000 cell/cm
2
 on to 
meshes which were anchored to the dishes using magnets The meshes were cultured in 
DMEM supplemented with 10% FBS, 1% PSA (10 U/mL penicillin, 10 g/L 
streptomycin, and 10 g/L amphotericin, Mediatech), and 1ng/ml TGF-β1 (Sigma) for 2 
or 4 weeks. To fabricate cylindrical constructs, meshes were wrapped around 3 mm glass 
rods so that the electrospun mesh fibers were aligned circumferentially and cells faced 
outward.  The rods were sterilized by autoclaving. After forming cylindrical constructs, 
specimens were cultured in DMEM containing 10% FBS, 1% PSA, 1ng/ml TGF-β1, and 
50 µg/mg ascorbic acid for either 2 or 4 weeks depending on prior treatment for a total 
culture time of 6 weeks. In experiment 1, cells were cultured on the mesh for 4 weeks 
prior to rolling, and then 2 weeks after. For experiment 2, cells were cultured for 2 
weeks before fabrication of a cylindrical construct, and then 4 weeks after.  
  
4.2.2 Mechanical Property Assessment 
 The mechanical properties of the constructs were measured following 6 weeks of 
culture. For mechanical property assessments, 3-5 mm ring segments were cut using 
surgical scissors from constructs that had been immersed in media overnight. 
Circumferential mechanical tests were performed using a modiﬁcation of the technique 
validated in Johnson et al.
91
 Calipers were used to measure the dimensions of each 
construct segment. Each ring was then mounted onto an Instron 3342 equipped with a 10 
N load cell using custom brackets.
137
 The ring segments were exposed to uniaxial strain 
 47 
at a rate of 6 mm/min until failure. Applied stress was calculated from the measured 
force by approximating the area of force application as two rectangles, each with sides 
equal to the width and wall thickness of the ring. The gauge length, lg, was taken as the 
inner diameter, Dv, of the unstretched ring plus the wall thickness, hv. The incremental or 
tangential modulus, E, of each sample was defined as the slope of the resulting stress–
strain curve at a reference stress of 20 kPa to mimic the circumferential stress 
experienced by vessels under physiological pressures (~0.5 Pavg Dv /hv ).
152
 The ultimate 
tensile strength (UTS) of the samples was defined as the maximum stress applied prior 
to failure. 
 
4.2.3 Construct Analyses 
 After 6 weeks total culture time, the static and dynamic constructs were 
harvested for biochemical and mechanical analyses. Each construct was cut into 5 ring 
segments, each ~3-5 mm in length. The two end-segments were discarded. One segment 
per construct was allocated for mechanical testing. The remaining sections were 
immersed in formalin overnight, after which they were allocated for histological or 
biochemical assays.  Mechanical testing was performed as described above. Details of 
the mechanical and histological analyses are given in the following sections. 
 
4.2.4 Biochemical Analyses 
 Samples for biochemical analyses were transferred to 2 mL screw-cap microfuge 
tubes containing 1.5 ml of lysis buffer (PBS containing 1% Triton X-100, 0.5% SDS, 
and 100 µg/mL PMSF) and 1 mL of 3.2 mm stainless steel beads. Each sample segment 
was homogenized at 4800 rpm in a Bead-Beater homogenizer (Biospec, Bartlesville) in 
10 s cycles with 1 min intermediate cooling on ice. Each sample was analyzed for 
collagen I(α1) (COL1A1, clone D-13), collagen III(α1) (COL3A1; clone S-17), and 
GAPDH (clone V-18) via competitive ELISA. In brief, peptide corresponding to the 
immunogen for each antibody were obtained from Santa Cruz Biotechnology (SCBT) 
and used to coat EIA plates at either 500 ng (collagen III peptides) or 2000 ng (collagen 
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I and GAPDH peptides) per well, after which the wells were blocked with BSA. At the 
time of analysis, samples were incubated with primary antibody for 1h, after which the 
mixtures were applied to the coated plates for 1 h. Standards were prepared by similarly 
incubating primary antibody with varying levels of immunogen peptide for 1 h, followed 
by application to coated plates. For both samples and standards, bound primary antibody 
was detected using appropriate HRP-conjugated secondary antibody, followed by 
application of 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (Sigma) and 
monitoring of absorbance at 410 nm. 
 
4.2.5 Histological Analyses 
 Histological sections were fixed in formalin overnight at 4 °C, embedded in OCT 
media, and cut into 10 μm sections. ECM deposition and cell phenotype were analyzed 
in 2 sections per sample using standard immunohistochemical technique. In brief, 
rehydrated sections were blocked by 30 min exposure to Terminator (Biocare Medical). 
Primary antibodies for collagen type I (Rockland Immunochemicals, Gilbertsville), and 
collagen type III (Rockland Immunochemicals) were diluted in PBS containing 3% BSA 
and 0.5% Tween 20 and for 1 h at room temperature. Bound primary antibody was 
detected by using an appropriate HRP-conjugated secondary antibody (Jackson 
Immunoresearch) followed by application of the chromogen 3,3‟-Diaminobenzidine 
(DAB; SCBT) Sections were then dehydrated with graded alcohol followed by xylene, 
and then mounted using polymount (Polysciences). Stained sections were imaged using 
an Axiovert microscope (Zeiss). 
 
4.2.6  Statistical Analyses 
 Data are reported as mean ± standard error of the mean. Comparison of sample 
means was performed by one-way ANOVA, p < 0.05. 
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4.3 Results and Discussion 
 
Cylindrical mesh scaffolds were produced by rolling a PEUUR electrospun mesh 
pre-seeded with 10T1/2 mouse mesenchymal cells, around a mandrel and securing the 
ends with ties. After either two or four weeks in culture, this process resulted in multiple 
layers of electrospun mesh secured by ECM produced by the cells. The ECM was found 
between and throughout the layers of the mesh. After 6 weeks total culture time, 
mechanical testing was performed followed by the completion of biochemical and 
histological analysis to determine the feasibility of using this system as a TE ligament 
graft. 
 
Figure 14: ECM-mesh, fibrin-mesh, and PEUUR electrospun mesh mechanical 
responses. (A) Compares a representative circumferential stress-strain response for the 
two fabrication methods. Experiment 1 had a 2 week culture time after rolling while 
experiment 2 had 4 weeks of culture after rolling. These are compared to the mechanical 
properties of a pure PEUUR electrospun mesh ring and a fibrin electrospun-mesh 
composite, adapted from McMahon et al
177
.  
 
 
Figure 14- part A shows the typical shape of a stress-strain curve from the two 
culture methods compared with a purely electrospun mesh ring segment.  Single 
component scaffolds are generally unable to mimic the non-linear stress-strain behavior 
characteristics seen in native ligament. This is seen in the linear behavior of the mesh 
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ring. The fibrin-electrospun mesh composite was able to mimic the behavior of native 
ligaments, but lost much of the tensile strength associated with the pure mesh.
177
 The 
construct labeled experiment 1 retains this biphasic stress-strain response, but 2 weeks of 
culture after rolling doesn‟t allow sufficient bonding time for the cells to produce strong 
and integrated ECM. The construct produced in experiment 2 shows the necessary 
behavior but retains much of the tensile modulus from the purely electrospun mesh (~1 
MPa). This can be explained by the increased culture time following cylindrical 
construct fabrication, which allowed the cells to deposit more ECM, but also because the 
cells had additional time to remodel this ECM into a more ideal network. The UTS of 
both of the experimental formulations was lower than that of the fibrin-electrospun mesh 
composite, but may be improved with additional culture time.    
 
 
Figure 15: Immunostaining and biochemical comparison of fabrication methods (A) 
ELISA results for collagen I (col I) and collagen III (col 3) normalized to housekeeping 
protein GAPDH. (B) Representative images of transverse sections through composite 
constructs from both fabrication methods following immunostaining for collagen I and 
collagen III. 
 
 
Both collagen I and collagen III production were slightly lower with 
longer culture after rolling, although these differences weren‟t significant (Figure 
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15- part A). This indicates that it may not be the about of ECM produced, but the 
arrangement of this ECM which is causing the increased mechanical properties 
exhibited by the ECM-mesh composites with longer culture time after rolling into 
a cylindrical construct. ECM remodeling is a continuous process in the body. 
Remodeling, common during wound healing, results in increased tensile strength, 
and can occur months to even years after injury. 
178
 
Cumulatively, the present results indicate that ECM-electrospun mesh 
composites warrant further investigation for ligament tissue engineering. Further 
studies will focus on increasing the cell infiltration through the mesh using a 
pressure difference 
179
 to pull the cells into the scaffold. This would make the 
process more clinically viable. Also, the expression of ECM components and 
phenotype markers has been shown to increase with stretch,
166
 so future studies 
will incorporate mechanical conditioning. 
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CHAPTER V  
INORGANIC-ORGANIC HYBRID SCAFFOLD FOR 
OSTEOCHONDRAL REGENERATION* 
 
5.1 Introduction 
 
The cruciate ligaments of the human knee withstand a variety of tensile and 
torsional forces during the course of normal daily routine and athletic activity. Damage 
can result in pain, joint instability and dysfunction, and eventual degenerative joint 
disease.
180
 As such, approximately 150,000 surgical procedures are performed to treat 
injured anterior cruciate ligaments (ACLs) each year in the United States alone.
2
 
Currently, autologous tissue is the preferred graft material for ACL reconstruction.
181
 
However, the limited supply of autologous tissue suitable for grafting and the risk of 
donor site morbidity complicate the use of autologous grafts.
182
 Tissue engineering is an 
alternative approach for ligament repair that may avoid many of limitations associated 
with autografts. 
Although rapid progress has been achieved in ligament tissue engineering over 
the past decade, engineered ligaments have, thus far, generally failed to achieve 
mechanical properties sufficiently similar to their native counterparts to serve as viable 
grafts.
183
 In addition, these engineered tissues usually lack the osteochondral interface 
critical to the appropriate transfer of load between ligament and bone.
183
 Since graft 
failure frequently results from poor integration of the replacement tissue with associated 
bone,
184
 the ability to regenerate the bone-ligament osteochondral interface would be  
advantageous in ligament reconstruction.  
_____________ 
*Reprinted with permission from “Inorganic-organic hybrid scaffolds for osteochondral regeneration” by 
Munoz-Pinto DJ, McMahon RE, Kanzelberger MA,  Jimenez-Vergara AC, Grunlan MA, Hahn MS 
Journal of Biomedical Research Part A. Copyright (2010)  by Wiley Periodicals, Inc. 
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 In orthopaedic tissue engineering, interfaces between tissues have a distinct role 
in the proper load transfer, making them crucial to tissue function.
185
 These interfaces 
usually have physical and chemical properties differing from the tissues they connect. 
Failure to incorporate this tissue-to-tissue interface has been reported to compromise 
graft stability and long-term clinical outcome of ligament reconstructions.
185-187
 For 
ligament or tendon tissue, the transition from bone occurs in three distinct regions: 
ligament, fibrocartilage, and bone. The fibrocartilage is further divided into calcified and 
non-calcified zones.
188
 Thus, a scaffold which promotes a spatially-regulated transition 
in cell behavior from osteoblast-like to chondrocyte-like would be desirable for 
osteochondral regeneration.
189
 For instance, a recent osteochondral tissue engineering 
study employed a scaffold containing a spatial gradient in levels of a retrovirus encoding 
for Runx2, an osteogenic transcription factor.
190
 This design induced a spatially-graded 
transdifferentiation of associated dermal fibroblasts into osteoblast-like cells. Similarly, 
an extensive body of literature indicates that appropriately tailoring scaffold inorganic 
composition (hydroxyapatite and bioactive glass) can enhance its osteoconductivity.
191-
194
 Recently, silica-calcium phosphate composite scaffolds were shown to induce 
increasing osteoblast alkaline phosphatase activity
195
 and osteocalcin expression
196
 with 
increasing silica (decreasing calcium phosphate) content. Another work demonstrated 
elevated alkaline phosphatase activity in osteoblasts cultured on gelatin scaffolds of 
increasing siloxane content.
197
 
We employed hydrogels composed of varying ratios of poly(ethylene glycol) 
(PEG) to star poly(dimethylsiloxane) (PDMSstar). PEG was selected for the organic 
component since spatial gradients can readily be fabricated in hydrogels prepared from 
diacrylate-derivatized PEG due to its photoactivity. For instance, PEG hydrogels with a 
continuous linear material property gradient can be generated by simple adaptation of 
the equipment normally used to make gradient polyacrylamide gels for 
electrophoresis.
198
 More complex spatial gradients or patterns can be fabricated using 
photolithographic techniques
199-201
 PDMS was chosen over other polysiloxanes due to its 
known biocompatibility and its widespread use in biomedical applications
202
 In addition, 
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a star conformation of PDMS was selected over a linear form in order to reduce potential 
phase separation between the hydrophobic PDMS and hydrophilic PEG prior to hydrogel 
polymerization.
203
  
In the present study, rat calvarial osteoblasts were encapsulated in PEG gels of 
varying PDMSstar content, and the resulting modulation of cell behavior was examined. 
In assessing cell response, biochemical and histological analyses were conducted for 
extracellular matrix (ECM) components associated with mature bone (collagen type I, 
osteocalcin, and calcium phosphate (CaP)) and fibrocartilage (collagen types I and II as 
well as chondroitin sulfate proteoglycan (CSPG)).
188
 To gain insight into the signaling 
underlying observed cell responses, immunostaining for the chondrogenic transcription 
factor sox9
204
 was also performed.  
 
5.2 Materials and Methods 
 
5.2.1 Synthesis of methacrylate-derivatized PDMSstar (PDMSstar-MA)  
Methacrylate-derivatized star PDMS (PDMSstar -MA) was prepared via a two 
step synthetic strategy per a modiﬁcation of the methodology validated in Grunlan et 
al.
205
 First, silane-terminated PDMSstar (PDMSstar -SiH) was prepared by the acid-
catalyzed equilibration of octamethylcyclotetrasiloxane with 
tetrakis(dimethylsiloxane)silane. The desired PDMSstar Mw of ~14 kDa was achieved by 
appropriately setting the ratio of these two components.
205
 Brieﬂy, 
octamethylcyclotetrasiloxane (30 g, 0.10 mol) and tetrakis(dimethylsiloxane)silane (0.5 
g, 1.5 mmol) were combined in a 100 mL round bottom ﬂask and purged with N2. Triﬂic 
acid (15 μL) was then added and the reaction was allowed to stir for 1 h at 90oC. After 
cooling, the pH was neutralized by combining with MgCO3 (0.5 g) and dichloromethane 
(DCM, 20 mL) and stirring for 2 h. After ﬁltration through a pad of Celite, the volatiles 
were removed under reduced pressure. In this way, PDMSstar-SiH was obtained (26.3 g, 
86% yield) as a colorless liquid and subsequently characterized by 
1
H NMR, 
13
C NMR, 
IR, and gel permeation chromatography (GPC).  
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The silane terminal groups of PDMSstar-SiH were then converted into 
photosensitive moieties by the hydrosilylation reaction of PDMSstar-SiH and allyl 
methacrylate. 25 Brieﬂy, PDMSstar-SiH (6 g, 0.72 mmol) was combined with 10 mL of 
dry toluene in a 100 mL round bottom ﬂask and purged with N2. After Karstedt‟s 
catalyst (Pt-divinyltetramethyldisiloxane complex in xylene, 2% Pt; 15 lL) was added, 
the reaction was heated under constant stirring to 45
o
C. Allyl methacrylate (0.39 mL, 2.9 
mmol) was added to this solution via an addition funnel over 15 min, after which the 
reaction was heated to 90
o
C and stirred overnight. Completion of the reaction was 
conﬁrmed by the disappearance of the Si−H (~2100 cm-1) absorbance in the IR 
spectrum. The reaction mixture was decolorized by reﬂuxing with activated carbon for 
12 h. After ﬁltration, the volatile side products were removed under reduced pressure. In 
this way, methacrylate-derivatized PDMSstar (PDMSstar-MA) was obtained (5.23 g, 82% 
yield) and subsequently characterized by 
1
H NMR.  
 
 5.2.2 Preparation of Diacrylate-Terminated PEG 
Photosensitive acrylate groups were introduced to the terminal ends of linear 
PEG (MW ~3.4 kDa, Sigma) per established protocols.
200
 Brieﬂy, PEG (10 g, 3.3 mmol) 
and dry DCM (50 mL) were combined in a 100 mL round bottom ﬂask and purged with 
N2. Triethylamine (0.96 mL, 6.6 mmol) was added slowly to the solution followed by 
the dropwise addition of acryloyl chloride (1.08 mL, 13.2 mmol). The reaction mixture 
was allowed to stir at room temperature overnight. Removal of HCl was accomplished 
by washing the mixture with 2M K2CO3 and separating into aqueous and organic phases. 
The organic (DCM) phase was then dried with anhydrous MgSO4, and diacrylate-
derivatized PEG (PEG-DA) was precipitated in diethyl ether and dried under vacuum. In 
this way, PEG-DA was obtained and subsequently characterized by 
1
H NMR. 
 
5.2.3 Synthesis of Acrylate-Derivatized Cell Adhesion Ligand 
Cell adhesion peptide RGDS (American Peptide) was reacted with acryloyl-
PEG-N-hydroxysuccinimide (ACRL-PEG-NHS, Mw ~3.4 kDa, Nektar) at a 1:1 molar 
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ratio for 2 h in 50 mM sodium bicarbonate buffer, pH 8.5. 19,20 The product (ACRL-
PEG-RGDS) was puriﬁed by dialysis, lyophilized, and stored at -20oC until use. 
 
5.2.4 Hydrogel Fabrication 
Three distinct hydrogel precursor solutions were prepared by dissolving desired 
levels of PDMSstar-MA and PEG-DA in HEPES buffered saline (HBS; 10 mM HEPES, 
150 mM NaCl, pH 7.4). Each solution contained 10 weight percent (wt %) total polymer 
comprised of one of the following three wt ratios of PDMSstar-MA to PEG-DA: 0:100, 
1:99, and 5:95. Ten microliters of photoinitiator consisting of a 30 wt % solution of 2,2-
dimethyl-2-phenyl-acetophenone in N-vinylpyrrolidone was added per milliliter of 
precursor solution. The resulting solutions were mixed by vortex and then ﬁltered (0.22 
μm PES membrane, Millipore) immediately prior to being pipetted into 0.5-mmthick 
transparent rectangular molds. In addition to performing a sterilization function, the 
ﬁltration process served to create a ﬁne and stable dispersion of hydrophobic PDMSstar-
MA within the aqueous PEG-DA solution. The precursor solutions were polymerized by 
2 min exposure to longwave UV light (Spectroline, ~6 mW/cm
2
, 365 nm).  
 
5.2.5 Hydrogel Composition 
To verify the incorporation of varying levels of PDMSstar into the fabricated 
hydrogels, compositional analysis was performed using a Kratos Axis Ultra X-ray 
photoelectron spectrometer (XPS) with a monochromatized Mg Ka source. Swollen 
hydrogels were transferred to dIH2O for 24 h and then dried under vacuum. The dried 
gel discs were then placed onto steel gravity mounts and loaded into the XPS. Elemental 
atomic percent compositions were obtained from survey spectra, which were performed 
from 0 to 1100 eV. High-resolution analyses with pass energies of 40 eV were 
performed at a take-off angle of 90
o
. The binding energies were referenced to C
1s
 peak at 
285.0 eV. The raw data was quantiﬁed and analyzed using XPS Peak Processing 
software.
206
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5.2.6 Contact Angle and Protein Adsorption 
The dependence of gel surface hydrophilicity and protein adsorption on increased 
PDMSstar content was evaluated. Static contact angle measurements were performed on 
swollen PDMSstar -PEG hydrogels using a CAM-200(KSV Instruments) contact angle 
measurement system equipped with an autodispenser, video camera, and dropshape 
analysis software. Brieﬂy, 5 μL of dIH2O was dispensed onto each hydrogel surface, and 
the angle of the water droplet relative to the surface was monitored for a period of 2 min. 
Five separate measurements were performed for each hydrogel formulation.  
For protein adsorption analyses, four 6-mm diameter samples were harvested 
from swollen hydrogels of each formulation. These samples were exposed to a 50 μg/mL 
solution of AlexaFluor 488-labeled ﬁbronectin in PBS. Fibronectin adsorption was 
selected for characterization based on previous bone tissue engineering studies.
207,208
 
Following 1 h at room temperature, the protein solutions were removed and exchanged 
with PBS. One hour and 12 h after removal of the protein solution, the ﬂuorescence of 
the hydrogel surfaces was monitored using a Zeiss Axiovert 200 microscope and 
separately using a microplate reader at ex/em 488/532. Prior to each time point 
measurement, the PBS was removed and exchanged with fresh PBS. A ﬁbronectin 
standard curve was used to convert each ﬂuorescence signal to a protein concentration.  
 
5.2.7 Hydrogel Swelling  
To characterize equilibrium swelling, 8-mm diameter samples were cored from 
each PEG-DA hydrogel immediately following polymerization and weighed. The 
samples were then transferred to HBS supplemented with 0.05 wt % sodium azide 
(HBS-azide). After 24 h, samples were blotted and weighed. The swollen gels were then 
dried in vacuo and their dry weight recorded. As PEG-DA hydrogels are primarily water, 
the increase in weight with swelling can be directly related to the increase in gel volume 
(V) with swelling, i.e.,  

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initial
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. S values were found to be 1.10 ± 0.01, 
1.07 ± 0.01, and 1.11 ± 0.01 for the 0:100, 1:99, and 5:95 gels, respectively. 
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These ratios were used to calculate the amount of cells and ACRL-PEG-RGDS to be 
added to each hydrogel precursor solution so as to ensure the desired postswelling cell 
density and RGDS concentration. The dry weight measures were used to calculate the 
swelling ratio for each formulation: R = (swollen weight/dry weight). This ratio served 
as an indicator of gel crosslink density.  
 
5.2.8 Hydrogel Mesh Size  
PEG-DA hydrogel mesh structure cannot be visualized using techniques such as 
conventional scanning electron microscopy (SEM). 
209
 Thus, a variety of methods to 
estimate PEG-DA hydrogel mesh size have been developed, including correlations 
linking measurable quantities, such as equilibrium hydrogel swelling and PEG-DA Mn, 
to mesh size.
210,211
 Although these correlations yield reasonable mesh size estimates for 
homopolymer hydrogels, 
210,211
 these correlations cannot readily be applied to PDMSstar 
–PEG hybrid hydrogels. Thus, in this study, hydrogel mesh size was characterized via 
dextran diffusion based on an adaptation of the methodology of Watkins et al. 
212
 
A series of PDMSstar -PEG hydrogels were prepared, each containing 1 μM 
ACRL-PEG-RGDS postswelling. These gels were allowed to swell overnight at 37
o
C in 
HBS-azide, after which 8 mm discs were cored from each sample. FITC-labeled dextran 
(70 kDa, Sigma) was dissolved at 0.05 mg/mL in HBS-azide and added at 1 mL per 
hydrogel disc. Dextran was then allowed to diffuse into the hydrogels for 24 h at 37
o
C. 
Each gel disc was gently blotted and transferred to 1 mL fresh HBS-azide. Dextran that 
had penetrated into the hydrogels was then permitted to diffuse out into the surrounding 
solution at 37
oC. After 24 h, the ﬂuorescence of the HBS-azide solution surrounding 
each disc was measured at ex/em 488/532. Dextran standard curves were used to convert 
each ﬂuorescence signal to microgram dextran. For each gel sample, these dextran 
readings were divided by gel weight to yield a quantitative indicator of hydrogel 
permissivity (C). These permissivity measures were used to estimate the relative mesh 
size (n) of each hydrogel (x) as follows:  
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PEGPDMS
x
x C
C
100:0
~ . 
 
5.2.9 Hydrogel Mechanical Properties  
PDMSstar -PEG hydrogels were prepared containing 1 μM ACRL-PEG-RGDS 
postswelling. Three 8-mm discs were cored from each swollen gel and mechanically 
tested under unconstrained compression at room temperature using an Instron 3342. 
Following application of a 0.01 N preload, each hydrogel was subjected to 10 μm cyclic 
compression (~1% cyclic strain) at 1 Hz. The compressive modulus of each hydrogel 
was extracted from the resulting stress-strain data. 
 
5.2.10 Cell Expansion 
Cryopreserved rat calvarial osteoblasts (Dominion Pharmakine) were thawed and 
expanded at 37
o
C/5% CO2 in Dulbecco‟s Modiﬁed Eagles‟ Media (DMEM, Hyclone) 
supplemented with 10% fetal bovine serum (FBS), and 100 mU/mL penicillin and 100 
mg/L streptomycin (Hyclone). 
 
5.2.11 Cell Encapsulation  
Osteoblasts at passage 6 were harvested and combined. Precursor solutions 
containing 10 wt % total polymer were prepared by dissolving PDMSstar -MA and PEG-
DA at ratios of 0:100, 1:99, and 5:95 in HBS followed by photoinitiator. These wt ratios 
will be used to refer to the various hydrogel formulations throughout the remainder of 
the text. ACRL-PEG-RGDS was added to each precursor solution to achieve 1 mM 
RGDS post-swelling. Each precursor solution was sterile-ﬁltered, immediately after 
which osteoblasts were added at a postswelling density of ~3 × 10
6
 cells/mL. The 
hydrogel slabs were transferred to Omnitrays (Nunc) ﬁtted with four sterile 
polycarbonate bars to simultaneously prevent gel ﬂotation and prevent gel contact with 
the tray bottom. Gels were maintained at 37
o
C/ 5% CO2 in DMEM supplemented with 
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10% FBS and 100 mU/mL penicillin and 100 mg/L streptomycin. Media was changed 
every 2 days. 
 
5.2.12 Day 3 Construct Analyses 
Following 3 days of culture to allow for complete hydrogel equilibration, 8-mm 
diameter samples were collected to characterize the initial mechanical properties of the 
cell-laden gels. These measures were conducted as described earlier to assess the impact 
of cells on initial bulk-average hydrogel material properties (since hydrogel modulus, 
mesh size, and swelling are interdependent).
213
 
 
5.2.13 Day 28 Construct Biochemical Analyses 
After 28 days total culture time, a series of 8-mm samples were collected from 
each hydrogel formulation for biochemical and histological analyses. Samples harvested 
for biochemical analyses were weighed, ﬂash-frozen in liquid nitrogen, and stored at -80 
o
C.  
 
5.2.14 DNA and Total Collagen Biochemical Analyses  
Hydrogel samples were digested for 72 h at 37
o
C in 1 mL of 0.12M NaOH per 
0.2 g hydrogel wet weight. Aliquots of the NaOH hydrolyzed samples (n = 3–6 per 
formulation) were neutralized and their DNA content determined using the PicoGreen 
assay (Invitrogen).
92
 DNA measures were translated to cell number using a conversion 
factor of 6.6 pg DNA per cell. Calf thymus DNA (Sigma) served as a standard.  
Levels of hydroxyproline were quantiﬁed as an indirect measure of total 
collagen. NaOH digested hydrogels (n = 3–5 per formulation) were further hydrolyzed 
for 18 h at 110
o
C in 6M HCl. The samples were then dried (Centrivap, Labconco) 
followed by resuspension in dIH2O and reaction with chloramine T and p-
dimethylbenzaldehyde reagents.
214
 Sample absorbance was read at 550 nm relative to 
that of l-4-hydroxyproline (Sigma). Total collagen content was estimated from measured 
hydroxyproline using the collagen type I conversion factor of 0.13 grams hydroxyproline 
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per gram collagen.
215
 For each assay, the standards used were subjected to the same 
association with PEG-DA and PDMSstar -MA and the same digestion conditions as the 
samples.  
 
5.2.15 Calcium and Alkaline Phosphatase Analyses  
Hydrogels (n = 2 per formulation) were transferred to 2 mL screw-cap microfuge 
tubes containing 1 mL of lysis buffer from the EnzoLyte FDP Alkaline Phosphatase 
assaykit and 1 mL of 3.2 mm stainless steel beads. Each sample was homogenized at 
4800 rpm in a Bead-Beater homogenizer (Biospec) in 10 s cycles with 1 min 
intermediate cooling on ice. Two hundred microliter aliquots of each sample 
homogenate were analyzed for alkaline phosphatase activity using EnzoLyte kit 
reagents. Total calcium was assessed from 5 lL aliquots of each sample homogenate 
using the Calcium CPC liquid color kit (Stanbio).  
 
5.2.16 Day 28 Histological Analyses 
To gain further understanding of the effects of hydrogel composition on the 
behavior of encapsulated cells, staining was conducted for ECM components associated 
with mature bone (collagen type I, osteocalcin, and CaP). Similarly, immunostaining for 
ﬁbrocartilage-associated ECM components (collagen type I, collagen type II, and CSPG) 
and for chondrogenic transcription factor sox9 was carried out. Samples harvested for 
histological analyses were ﬁxed with 10% formalin for 30 min, embedded in freezing 
media (Tissue-Tek), and cut into 35 μm sections. 
 
5.2.17 Immunostaining 
Immunostaining was conducted according to standard protocols. In brief, 
sections were blocked with peroxidase (Biocare Medical) for 30 min followed by 
Terminator (Biocare Medical) for 10 min. Primary antibody for osteocalcin [FL-95, 
Santa Crux Biotechnology (SCBT)], collagen type I (Rockland Immunochemicals), 
collagen type II (Rockland), CSPG (cs-56, SCBT), or sox9 (H-90, SCBT) was then 
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applied for 1 h following dilution in HBS. For the sox9 antibody, sections were 
permeabilized before antibody application with PBS containing 0.05% Triton-100X. For 
each antibody and hydrogel sample, 2–3 sections were stained. Bound primary antibody 
was detected by using AP-/HRP-conjugated secondary antibodies (Jackson 
Immunochemicals) followed by application of chromogen (LabVision). 
 
5.2.18 Van Kossa Staining 
To detect calcium deposits, sections were stained using a standard van Kossa 
staining kit (American MasterTech Scientiﬁc). In brief, rehydrated sections were rinsed 
with dIH2O, after which a 5% silver nitrate solution was applied. Sections were then 
exposed to full spectrum light in a humidiﬁed chamber for 45 min. After rinsing with 
dIH2O, sections were exposed to a 5% sodium thiosulfate for 2.5 min, brieﬂy rinsed, and 
mounted.  
 
5.2.19 Semiquantitative Histological Assessments 
For intracellular transcription factor sox9, cell counts were conducted to 
semiquantitatively evaluate immunostaining results. In addition, as deposited ECM 
remained localized around the parent cells in each hydrogel formulation (Figures 16 
and 17), the relative ECM protein production among hydrogel formulations could also 
be evaluated by cell counts. For each stained section (containing ~250 cells), these 
semiquantitative analyses were conducted per established protocols.
216-220
 In brief, 
staining intensity, di, was recorded for each cell, i, on a scale of 0–3, with 0 =„„no 
staining‟‟ and 3 = „„highest staining intensity among all sections for that antibody‟‟. The 
cumulative staining intensity, d, for a given antibody in a particular section was 
calculated as: d = (Σ di)/(total cell number). The d value for all sections of a given 
hydrogel formulation were averaged to yield an overall sample average for each 
antibody. Immunostained samples were imaged using an Axiovert 200 microscope 
(Zeiss). 
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5.2.20 Statistical Analyses 
Data are reported as mean ± standard deviation. Comparison of sample means was 
performed by ANOVA and Tukey‟s post hoc test (SPSS software), p < 0.05. 
 
5.3 Results and Discussion 
 
Hydrogels with a 0:100, 1:99, or 5:95 wt ratio of PDMSstar to PEG were prepared 
and their initial composition, mesh size, and mechanical properties characterized. 
Results from these characterization studies are summarized in Table 3. For each gel 
formulation, the mass percent of Si determined by XPS was consistent with the value 
predicted from the known Mn of both polymers and the wt ratio of PDMSstar-to-PEG in 
the precursor solution. These data support the successful incorporation of PDMSstar into 
the hydrogel networks. 
 
Table 3: Initial material properties of PDMSstar-PEG hybrid hydrogels 
PDMSstar to PEG 
Weight Ratio 
Relative Mesh 
Size (ξ) 
Modulus 
(kPa) 
Mass Percent Si 
Measured Predicted 
0:100 1.0 ± 0.1 167 ± 8 0.0 0.0 
1:99 1.1 ± 0.1 142 ± 4 0.6 0.4 
5:95 1.3 ± 0.1 142 ± 11 2.3 2.0 
 
The equilibrium diffusion of dextran was used to evaluate the mesh size of the 
1:99 and 5:95 gels relative to the 0:100 gels (i.e., relative to pure PEG hydrogels). Gel 
mesh size increased directionally with increasing PDMSstar content (Table 3). In 
contrast, the compressive moduli of the 1:99 (p = 0.018) and 5:95 (p = 0.015) hydrogels 
were significantly lower than that of the 0:100 gel (Table 3). Cell presence did not 
significantly impact observed initial bulk modulus assessments (data not shown), as 
expected given the relatively low initial cell density employed (~3x10
6
 cells/mL)
216
 The 
trends in both modulus and relative mesh size were consistent with a reduced crosslink 
density with increasing PDMSstar content, in agreement with the greater Mn of each 
PDMSstar arm relative to PEG.
213
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Table 4: PDMSstar-PEG hydrophilicity and Protein Adsorption 
PDMSstar to PEG 
Weight Ratio 
Contact Angle (o) Fibronectin Adsorption (ng/cm2) 
1 min 2 min 1 h 2 h 
0:100 38.8 ± 3.9 35.3 ± 4.9 48.9 ± 1.1 13.3 ± 2.3 
1:99 34.2 ± 3.4 32.0 ± 2.9 36.6 ± 3.0 14.5 ± 3.1 
5:95 37.0 ± 9.1 34.6 ± 8.5 33.0 ± 14.7 14.5 ± 3.1 
 
Since scaffold hydrophilicity
221
 and protein adsorption
191,208
 have been 
demonstrated to significantly impact osteoblast behavior, the surface hydrophilicity of 
and fibronectin adsorption on each hydrogel was investigated. In agreement with the 
literature,
206,222
 contact angle measures indicated that PDMSstar-PEG hybrid scaffolds 
maintained the hydrophilic character of pure PEG gels (Table 4). Similarly, the 
equilibrium (12 h) levels of fibronectin adsorption on the PDMSstar-containing gels were 
statistically indistinguishable from those on pure, “non-biofouling” PEG hydrogels (i.e., 
the 0:100 PDMSstar-PEG gels, Table 4).
223
 
Net cell density and ECM synthesis were evaluated in each hydrogel formulation 
to probe the influence of PDMSstar levels on osteoblast behavior. Based on DNA 
measures, the cell densities in the 0:100, 1:99, and 5:95 hydrogels at day 28 were 1.93 ± 
0.11, 1.93 ± 0.25 and 2.15 ± 0.19 million cells per gram, respectively. These data 
indicate that the net cell proliferation and loss over the time course of the study was 
similar across hydrogels and consistent with previous tissue engineering studies using 
“non-degradable” PEG-DA gels.224 In contrast, osteoblast total collagen production 
showed marked variations with hydrogel composition. Specifically, the total collagen 
levels in the 0:100 (p = 0.049) and 5:95 (p = 0.006) gels were approximately 2 times 
greater than in the 1:99 hydrogels (Figure 16- part A). 
To gain further insight into the observed total collagen results, immunostaining 
was conducted for collagen type I (associated with mature bone and, to a lesser extent, 
with fibrocartilage) and for collagen type II (associated with fibrocartilage).
188
 These 
histological analyses revealed a modulation of collagen types I and II with gel 
formulation. Collagen type II production was significantly higher in the 5:95 hydrogels 
relative to the 0:100 (p = 0.032) and 1:99 (p = 0.019) gels (Figure 16- part B). In 
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contrast, collagen type I expression appeared to decrease directionally with increasing 
hydrogel inorganic content, although this trend was not statistically significant (Figure 
16- part C).  
 
 
Figure 16: Relative expression of (A) total collagen, (B) collagen type II, (C) collagen 
type I, and (D) chondroitin sulfate across hydrogel formulations.*, significantly different 
from 0:100 gels; δ, significantly different from 1:99 gels. Representative images of 
staining for collagen type I and chondroitin sulfate are shown below the respective 
graphs. Scale bars apply to each image in the series and equal 50 µm. 
CSPG and sox9 (associated with fibrocartilage) as well as alkaline phosphatase, 
calcium deposits, and osteocalcin (mid-to-late term markers of bone tissue formation) 
were also assessed. CSPG levels were significantly higher in the 5:95 gels relative to the 
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0:100 hydrogels (p = 0.037, Figure 16- part D). In addition, sox9 expression increased 
with an increase in hydrogel inorganic content from 0:100 to 5:95 (p = 0.011, Figure 17- 
part A). Although no significant differences in alkaline phosphatase expression were 
noted among formulations (Figure 17- part B), van Kossa staining results revealed the 
levels of deposited calcium to be markedly higher in the 0:100 PDMSstar-PEG gels than 
in the 1:99 (p < 0.001) and 5:95 (p < 0.001) gels (Figure 17- part C). This decrease in 
calcium deposition with increasing hydrogel inorganic content was further reflected in 
the results from the CPC assay, which yielded 0.54 ± 0.13, 0.20 ± 0.14, and 0.18 ± 0.05 
ng calcium per cell for the 0:100, 1:99, and 5:95 gels, respectively. Similarly, 
osteocalcin levels were reduced in the 5:95 gels relative to both the 0:100 (p = 0.008) 
and 1:99 (p = 0.027) hydrogels (Figure 17- part D).  
In the present work, rat calvarial osteoblasts were encapsulated in a series of 
PEG-based hydrogels of increasing PDMSstar content. Osteoblasts appeared to 
transdifferentiate into chondrocyte-like cells with increasing scaffold inorganic content, 
as indicated by increased chondroitin sulfate and collagen type II production and by 
upregulation of sox9. Furthermore, the synthesis of bone-like matrix (calcium deposits 
and osteocalcin) decreased with increasing PDMSstar levels. Combined, the present 
results indicate that PDMSstar–PEG hybrid gels warrant further study as osteochondral 
regeneration matrices. 
 
 67 
 
Figure 17 : Relative expression of (A) sox9, (B) alkaline phosphatase, (C) calcium, and 
(D) osteocalcin levels on hydrogel composition.*, significantly different from 0:100 gels; 
δ, significantly different from 1:99 gels. Representative images of staining for collagen 
type I and chondroitin sulfate are shown below the respective graphs. Scale bars apply to 
each image in the series and equal 50 µm. 
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CHAPTER VI 
CONCLUSIONS AND FUTURE WORK 
 
 Imagine a day where a patient will go to the hospital with an injury and leave 
totally cured by a procedure that not only fixes the problem but uses the patients own 
cells to do it. Tissue engineering is moving towards the day where shelf-life is no longer 
an issue as treatments could be produced in situ. For example, for the tissue engineered 
ligament graft, fibrin could be harvested from the patients blood and mesenchymal stem 
cells could be extracted from adipose tissue in the surgical suite, and combined with an 
electrospun mesh and growth factors to aid in differentiation, to generate a completely 
degradable graft. With time, those cells will differentiate into ligament fibroblasts and 
generate the ECM necessary to withstand the tensile forces as the mesh degrades away. 
These studies may be in their infancy, but with advances in tissue engineering, this could 
be a routine hospital visit within a few decades.   
 Many aspects of the treatment of knee joint damage were examined in this 
research. First, to overcome many of the limitations of total knee replacement, a novel 
TiNb alloy was investigated. This alloy is composed of biocompatible constituents, and 
was shown to be at least as biocompatible as pure Ti. The corrosion resistance was also 
high, similar to that of Ti and better than NiTi, so the behavior of TiNb would be 
expected to be similar to Ti when implanted. These promising results warrant further 
investigation into processing techniques like producing a porous TiNb. 
Electrospun PEUUR meshes were explored, both as a composite scaffold with a 
hydrogel and alone, as a scaffold for ligament tissue engineering. In both studies, 
collagen I, collagen III, and elastin were deposited into the mesh by the mouse 
mesenchymal cells, indicating that the cells were producing the ECM proteins 
commonly found in ligament. Both of these fabrication methods produced the “toe-in” 
region commonly found in ligament tissue, and therefore better mimic native tissue than 
typical electrospun tubular scaffolds. The original mesh used had a tensile modulus of 1 
MPa, which is much lower than native ligament, whose modulus ranges from 111-141 
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MPa.
105
  Applying a similar technique to produce a construct using an electrospun mesh 
with higher tensile properties may generate a ligament graft with mechanical properties 
closer to those of native ligament. For example, this process could be used to produce a 
composite scaffold composed of a hydrogel and a stronger mesh, like the one produced 
by Huang et al. with a Young‟s modulus of 1.8 GPa.155 
 Optimizing the culture conditions for cell differentiation into ligament fibroblasts 
also needs to addressed before this method could be applied for in vivo ligament tissue 
engineering studies. In both electrospun mesh experiments, the main components of 
ligament ECM were produced, but growth factors could be applied to promote 
differentiation into ligament fibroblasts and the production of proper ECM. Future 
studies should also look at human mesenchymal stem cells to ensure they behave in a 
similar manner to the mouse cells used in the study. Finally, for a fully functional 
ligament tissue, the transition zone associated with the bony insertion ends of the 
ligaments must be recreated. An increase in organic content in the form of PDMS was 
shown to promote transdifferentiation of rat osteoblasts towards cartilage-like cells. 
Gradients in material properties of either the hydrogel or electrospun mesh could be 
utilized to promote differentiation of mesenchymal stem cells to recreate this transition 
region in ligament grafts. The gradient could either be produced in the hydrogel 
component or the electrospun component of the composite ligament graft. 
 
 
Figure 18: Tissue engineered ligament graft with gradient to promote osteochondral 
interface regeneration by altering properties of mesh to direct MSC differentiation 
 
 
Creating the gradient toward the ends of the electrospun component of the 
composite would simplify a procedure if this process ever were commercialized. A 
gradient can be produced by co-electrospinning two solutions onto a rotating drum. A 
charged guide is used to direct the fibers toward the drum and varying the offset of the 
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needles.
225
 This can be utilized to alter mechanical properties, organic content, 
hydrophobicity, or growth factor concentration, in order to promote cell differentiation 
from ligament to fibrocartilage to bone and recreate this transition zone (Figure 18). 
 The benefits of scaffolds produced by electrospinning include their high porosity, 
high tensile strength, and ability to orient fibers to influence cell behavior. An oriented 
electrospun mesh can be applied as a scaffold to generate oriented tissues such as 
vascular tissue or nerve tissue in addition to ligament. Our lab is interested in pursuing a 
hydrogel-electrospun mesh composite, similar to the one developed for ligament tissue 
engineering as a vascular tissue engineering system.  
 A major limitation to the widespread use of electrospinning for tissue 
engineering applications is the inability of cells to infiltrate into the material. The 
porosity of electrospun meshes is very high, but the pore size is generally less than 10 
μm so many groups have tried to increase cell infiltration by treating the meshes, 
producing meshes with larger pores
225
, and processing meshes. These processing 
methods include electrospinning directly onto layers of cells
226
 and using a vacuum to 
pull cells into the material.
179
  
 In an attempt to increase cell infiltration, a vacuum system similar to the one 
mentioned was used to pull cells into an elastomeric mesh for a preliminary vascular 
tissue engineering experiment. After one day in culture, a small sample was used to 
verify cell infiltration. Following two weeks in culture, a contractility test was 
successfully performed, indicating that the cells not only infiltrated the mesh, but were 
able to differentiate into smooth muscle like cells, form a network, and then contract 
with the addition of phenylephrine. With future ligament tissue engineering studies, this 
cell infiltration technique will be applied to ensure cells are dispersed throughout the 
scaffold and not just in between layers.  
 Figure 19 shows the gradient containing ligament graft as a treatment for a torn 
ACL. This graft contains adipose derived MSC who are directed to differentiate through 
the differences in organic content,
227
 mechanical properties,
228`
 the addition of chemical 
or biological factors
229
 or a combination, which would be determined through 
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experimentation. The osteochondral interface present in natural ligament would be 
integrated into the bony ends of the graft, and the scaffold would degrade as the cells 
construct ECM to produce a healthy, functional ACL. 
 
 
Figure 19: Process of treating a torn ACL with a TE ligament graft 
 
 
 Tissue engineering is a rapidly growing field with a great deal of potential to 
develop living substitutes for many tissues and organs. The form and function of 
defective or damaged body parts may be able to be replaced allowing for the 
regeneration of these tissues and the treatment or cure of many ailments and diseases.  
The introductory work in ligament and bone tissue engineering discussed may be able to 
be applied toward the development of future treatments of knee joint damage.  
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